activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470096	CHEMBL1032238	Inhibition of ACVR1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5903	Homo sapiens	INH	%	10.0
	2470096	CHEMBL1032238	Inhibition of ACVR1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5903	Homo sapiens	INH	%	10.0
Not Evaluated	2476595	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL5903	Homo sapiens	Activity		
Not Evaluated	2476798	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5903	Homo sapiens	Activity		
Not Evaluated	2478637	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5903	Homo sapiens	Activity		
Not Evaluated	2478840	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5903	Homo sapiens	Activity		
	2479695	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	2.75	CHEMBL5903	Homo sapiens	Activity	%	2.75
	2480694	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.1	CHEMBL5903	Homo sapiens	Activity	%	0.1
Not Evaluated	2577316	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5903	Homo sapiens	Activity		
Not Evaluated	2577519	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5903	Homo sapiens	Activity		
	2593521	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	9.2	CHEMBL5903	Homo sapiens	Activity	%	9.2
	2593724	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.3	CHEMBL5903	Homo sapiens	Activity	%	0.3
	2593990	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	1.25	CHEMBL5903	Homo sapiens	Activity	%	1.25
Not Evaluated	2594933	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5903	Homo sapiens	Activity		
Not Evaluated	2595136	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5903	Homo sapiens	Activity		
Not Evaluated	2595202	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5903	Homo sapiens	Activity		
Not Evaluated	2596333	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5903	Homo sapiens	Activity		
	2597602	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	8.25	CHEMBL5903	Homo sapiens	Activity	%	8.25
Not Evaluated	2597805	CHEMBL993459	Binding affinity to human ALK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5903	Homo sapiens	Activity		
	2895543	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895544	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895545	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895546	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895547	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895548	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895549	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895550	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895551	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1700.0	CHEMBL5903	Homo sapiens	Kd	nM	1700.0
	2895552	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895553	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895554	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	620.0	CHEMBL5903	Homo sapiens	Kd	nM	620.0
	2895555	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895556	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895557	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1900.0	CHEMBL5903	Homo sapiens	Kd	nM	1900.0
	2895558	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895559	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895560	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895561	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895562	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	5900.0	CHEMBL5903	Homo sapiens	Kd	nM	5900.0
	2895563	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895564	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2895565	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	2500.0	CHEMBL5903	Homo sapiens	Kd	nM	2500.0
	2896479	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896480	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896481	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896482	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896483	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896484	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896485	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896486	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896487	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896488	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	470.0	CHEMBL5903	Homo sapiens	Kd	nM	470.0
	2896489	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896490	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896491	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1900.0	CHEMBL5903	Homo sapiens	Kd	nM	1900.0
	2896492	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	2896493	CHEMBL1063697	Binding constant for ACVR1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	150.0	CHEMBL5903	Homo sapiens	Kd	nM	150.0
	2921450	CHEMBL1057561	Inhibition of ACVR1B assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	82.0	CHEMBL5903	Homo sapiens	Activity	%	82.0
	2921451	CHEMBL1057560	Inhibition of ACVR1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	3052520	CHEMBL1047771	Residual activity of ACV-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL5903	Homo sapiens	Residual activity	%	93.0
	3052772	CHEMBL1046505	Residual activity of ACV-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	96.0	CHEMBL5903	Homo sapiens	Residual activity	%	96.0
	3054081	CHEMBL1066599	Residual activity of ACV-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	89.0	CHEMBL5903	Homo sapiens	Residual activity	%	89.0
	3055368	CHEMBL1047771	Residual activity of ACV-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	89.0	CHEMBL5903	Homo sapiens	Residual activity	%	89.0
	3055620	CHEMBL1046505	Residual activity of ACV-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	87.0	CHEMBL5903	Homo sapiens	Residual activity	%	87.0
	3056925	CHEMBL1066599	Residual activity of ACV-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	91.0	CHEMBL5903	Homo sapiens	Residual activity	%	91.0
	3058245	CHEMBL1047771	Residual activity of ACV-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	85.0	CHEMBL5903	Homo sapiens	Residual activity	%	85.0
	3058497	CHEMBL1046505	Residual activity of ACV-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	81.0	CHEMBL5903	Homo sapiens	Residual activity	%	81.0
	3072843	CHEMBL1066599	Residual activity of ACV-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	97.0	CHEMBL5903	Homo sapiens	Residual activity	%	97.0
	3331815	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3333230	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3334635	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3336055	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3337441	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3337689	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3339020	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3339276	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3340583	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3341999	CHEMBL1168582	Inhibition of ACVR1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	3358442	CHEMBL1174056	Inhibition of ACVR1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL5903	Homo sapiens	INH	%	100.0
	3358884	CHEMBL1174056	Inhibition of ACVR1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL5903	Homo sapiens	INH	%	100.0
	3445018	CHEMBL1244712	Binding affinity to ACVR1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	75.0	CHEMBL5903	Homo sapiens	Kd	nM	75.0
	3448685	CHEMBL1244712	Binding affinity to ACVR1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	3448833	CHEMBL1244712	Binding affinity to ACVR1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	2500.0	CHEMBL5903	Homo sapiens	Kd	nM	2500.0
	3449548	CHEMBL1244712	Binding affinity to ACVR1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	3450281	CHEMBL1244712	Binding affinity to ACVR1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	3450902	CHEMBL1244712	Binding affinity to ACVR1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	3451192	CHEMBL1244712	Binding affinity to ACVR1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	uM	10.0
	6264904	CHEMBL1799787	Inhibition of ACVR1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL5903	Homo sapiens	INH	%	65.0
	6265628	CHEMBL1799787	Inhibition of ACVR1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL5903	Homo sapiens	INH	%	65.0
	6341011	CHEMBL1827636	Activity of ACVR1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	7567214	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	3400.0	CHEMBL5903	Homo sapiens	Kd	nM	3400.0
	7567673	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7568144	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7568612	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7569187	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7569647	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	440.0	CHEMBL5903	Homo sapiens	Kd	nM	440.0
	7570119	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7570567	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7571163	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7571620	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	620.0	CHEMBL5903	Homo sapiens	Kd	nM	620.0
	7572117	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7572533	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	29.0	CHEMBL5903	Homo sapiens	Kd	nM	29.0
	7573144	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	600.0	CHEMBL5903	Homo sapiens	Kd	nM	600.0
	7573601	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7573635	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	390.0	CHEMBL5903	Homo sapiens	Kd	nM	390.0
	7574104	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7574512	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7575122	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7575612	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7576077	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7576485	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	150.0	CHEMBL5903	Homo sapiens	Kd	nM	150.0
	7577113	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7577591	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	140.0	CHEMBL5903	Homo sapiens	Kd	nM	140.0
	7578061	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	4.0	CHEMBL5903	Homo sapiens	Kd	nM	4.0
	7578466	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	150.0	CHEMBL5903	Homo sapiens	Kd	nM	150.0
	7578662	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7579036	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7579486	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1900.0	CHEMBL5903	Homo sapiens	Kd	nM	1900.0
	7579960	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7580429	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7580832	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1900.0	CHEMBL5903	Homo sapiens	Kd	nM	1900.0
	7581020	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7581405	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7581850	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7582321	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7582785	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	4800.0	CHEMBL5903	Homo sapiens	Kd	nM	4800.0
	7583185	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7583366	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7583763	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7584208	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7584679	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7585696	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7586104	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7586550	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7587033	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7587657	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7588076	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	75.0	CHEMBL5903	Homo sapiens	Kd	nM	75.0
	7588529	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7588558	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7589009	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7589622	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7590046	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7590545	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	2500.0	CHEMBL5903	Homo sapiens	Kd	nM	2500.0
	7590996	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7591595	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7592047	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7592520	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7592973	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7593555	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7594027	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7594500	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7594952	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7595088	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7595532	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1700.0	CHEMBL5903	Homo sapiens	Kd	nM	1700.0
	7596006	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7596477	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7596924	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	470.0	CHEMBL5903	Homo sapiens	Kd	nM	470.0
	7597060	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7597513	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7597986	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
	7598456	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	160.0	CHEMBL5903	Homo sapiens	Kd	nM	160.0
	7598898	CHEMBL1908516	Binding constant for ACVR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5903	Homo sapiens	Kd	nM	10000.0
inactive	9619876	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619877	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619878	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619879	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)c1ccc(NC(=O)CC2Nc3ccccc3NC2=O)cc1		CHEMBL1985469	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619880	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619881	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619882	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619883	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9619884	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619885	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619886	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619887	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	10.0	CHEMBL5903	Homo sapiens	pKi		8.0
active	9619888	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	794.33	CHEMBL5903	Homo sapiens	pKi		6.1
inactive	9619889	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619890	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619891	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619892	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
inactive	9619893	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619894	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619895	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619896	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
active	9619897	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	=	Ki	nM	50118.72	CHEMBL5903	Homo sapiens	pKi		4.3
active	9619898	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	794.33	CHEMBL5903	Homo sapiens	pKi		6.1
inactive	9619899	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619900	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619901	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
active	9619902	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	7943.28	CHEMBL5903	Homo sapiens	pKi		5.1
inactive	9619903	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619904	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619905	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	501.19	CHEMBL5903	Homo sapiens	pKi		6.3
inactive	9619906	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619907	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	2511.89	CHEMBL5903	Homo sapiens	pKi		5.6
active	9619908	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
active	9619909	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Ki	nM	1584.89	CHEMBL5903	Homo sapiens	pKi		5.8
inactive	9619910	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
active	9619911	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	39810.72	CHEMBL5903	Homo sapiens	pKi		4.4
inactive	9619912	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619913	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619914	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619915	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
inactive	9619916	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619917	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	79.43	CHEMBL5903	Homo sapiens	pKi		7.1
active	9619918	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	794.33	CHEMBL5903	Homo sapiens	pKi		6.1
active	9619919	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	=	Ki	nM	794.33	CHEMBL5903	Homo sapiens	pKi		6.1
inactive	9619920	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619921	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	501.19	CHEMBL5903	Homo sapiens	pKi		6.3
inactive	9619922	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619923	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	251.19	CHEMBL5903	Homo sapiens	pKi		6.6
active	9619924	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	39.81	CHEMBL5903	Homo sapiens	pKi		7.4
inactive	9619925	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619926	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	=	Ki	nM	1000.0	CHEMBL5903	Homo sapiens	pKi		6.0
active	9619927	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
active	9619928	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9619929	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619930	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619931	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619932	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619933	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619934	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	125.89	CHEMBL5903	Homo sapiens	pKi		6.9
inactive	9619935	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619936	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619937	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619938	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619939	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	19952.62	CHEMBL5903	Homo sapiens	pKi		4.7
inactive	9619940	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619941	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619942	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619943	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	158.49	CHEMBL5903	Homo sapiens	pKi		6.8
inactive	9619944	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619945	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	=	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
active	9619946	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	3.162	CHEMBL5903	Homo sapiens	pKi		8.5
inactive	9619947	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619948	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9619949	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619950	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619951	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9619952	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619953	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619954	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
inactive	9619955	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619956	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619957	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619958	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619959	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
active	9619960	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	10000.0	CHEMBL5903	Homo sapiens	pKi		5.0
inactive	9619961	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619962	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619963	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619964	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619965	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619966	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619967	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	63.1	CHEMBL5903	Homo sapiens	pKi		7.2
inactive	9619968	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1cccc(Br)c1c2=O		CHEMBL1976158	<	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
inactive	9619969	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619970	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619971	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619972	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
inactive	9619973	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619974	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619975	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	501.19	CHEMBL5903	Homo sapiens	pKi		6.3
active	9619976	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	1000.0	CHEMBL5903	Homo sapiens	pKi		6.0
active	9619977	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
inactive	9619978	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619979	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619980	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	63.1	CHEMBL5903	Homo sapiens	pKi		7.2
inactive	9619981	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619982	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619983	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619984	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	6309.57	CHEMBL5903	Homo sapiens	pKi		5.2
inactive	9619985	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619986	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9619987	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619988	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
inactive	9619989	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(=O)[nH]c2[nH]nc(-c3cccc(C(F)(F)F)c3)c12		CHEMBL1991377	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619990	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619991	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619992	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
inactive	9619993	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9619994	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9619995	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	199.53	CHEMBL5903	Homo sapiens	pKi		6.7
active	9619996	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	158.49	CHEMBL5903	Homo sapiens	pKi		6.8
active	9619997	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	39.81	CHEMBL5903	Homo sapiens	pKi		7.4
inactive	9619998	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
inactive	9619999	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9620000	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1000.0	CHEMBL5903	Homo sapiens	pKi		6.0
inactive	9620001	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9620002	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9620003	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9620004	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9620005	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9620006	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9620007	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9620008	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623556	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623557	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623558	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623559	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	39810.72	CHEMBL5903	Homo sapiens	pKi		4.4
active	9623560	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	100.0	CHEMBL5903	Homo sapiens	pKi		7.0
active	9623561	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	=	Ki	nM	125.89	CHEMBL5903	Homo sapiens	pKi		6.9
active	9623562	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	39810.72	CHEMBL5903	Homo sapiens	pKi		4.4
active	9623563	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
inactive	9623564	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623565	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	50.12	CHEMBL5903	Homo sapiens	pKi		7.3
inactive	9623566	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623567	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623568	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623569	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623570	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623571	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
inactive	9623572	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623573	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623574	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623575	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623576	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623577	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623578	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	=	Ki	nM	63.1	CHEMBL5903	Homo sapiens	pKi		7.2
active	9623579	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	=	Ki	nM	100.0	CHEMBL5903	Homo sapiens	pKi		7.0
active	9623580	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623581	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623582	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623583	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623584	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	=	Ki	nM	2511.89	CHEMBL5903	Homo sapiens	pKi		5.6
inactive	9623585	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623586	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	158.49	CHEMBL5903	Homo sapiens	pKi		6.8
active	9623587	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
inactive	9623588	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623589	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623590	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623591	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623592	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	39.81	CHEMBL5903	Homo sapiens	pKi		7.4
inactive	9623593	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623594	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623595	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623596	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623597	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623598	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	199.53	CHEMBL5903	Homo sapiens	pKi		6.7
active	9623599	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	25118.86	CHEMBL5903	Homo sapiens	pKi		4.6
inactive	9623600	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
active	9623601	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	1000.0	CHEMBL5903	Homo sapiens	pKi		6.0
inactive	9623602	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623603	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623604	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623605	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	=	Ki	nM	125.89	CHEMBL5903	Homo sapiens	pKi		6.9
active	9623606	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
inactive	9623607	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623608	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	794.33	CHEMBL5903	Homo sapiens	pKi		6.1
active	9623609	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	398.11	CHEMBL5903	Homo sapiens	pKi		6.4
inactive	9623610	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623611	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1nc2ncc(-c3ccccc3)cn2n1		CHEMBL2002480	=	Ki	nM	39810.72	CHEMBL5903	Homo sapiens	pKi		4.4
inactive	9623612	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623613	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncnc2nc3ccccc3n12		CHEMBL1983884	<	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
inactive	9623614	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623615	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623616	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623617	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623618	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623619	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623620	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	19952.62	CHEMBL5903	Homo sapiens	pKi		4.7
inactive	9623621	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623622	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
active	9623623	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9623624	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623625	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623626	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	100.0	CHEMBL5903	Homo sapiens	pKi		7.0
active	9623627	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1NS(=O)(=O)c2ccc(Cl)cc21		CHEMBL1967612	=	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
inactive	9623628	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623629	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623630	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	63095.73	CHEMBL5903	Homo sapiens	pKi		4.2
active	9623631	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	63.1	CHEMBL5903	Homo sapiens	pKi		7.2
active	9623632	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	12589.25	CHEMBL5903	Homo sapiens	pKi		4.9
active	9623633	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	=	Ki	nM	15.85	CHEMBL5903	Homo sapiens	pKi		7.8
inactive	9623634	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623635	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623636	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623637	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623638	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	=	Ki	nM	1584.89	CHEMBL5903	Homo sapiens	pKi		5.8
active	9623639	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623640	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623641	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	12589.25	CHEMBL5903	Homo sapiens	pKi		4.9
inactive	9623642	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623643	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CC)CCNc1ccc(O)c2ccccc12		CHEMBL576113	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623644	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	100.0	CHEMBL5903	Homo sapiens	pKi		7.0
active	9623645	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	=	Ki	nM	125.89	CHEMBL5903	Homo sapiens	pKi		6.9
inactive	9623646	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623647	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	316.23	CHEMBL5903	Homo sapiens	pKi		6.5
inactive	9623648	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623649	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	=	Ki	nM	63095.73	CHEMBL5903	Homo sapiens	pKi		4.2
inactive	9623650	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623651	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623652	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623653	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623654	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	50.12	CHEMBL5903	Homo sapiens	pKi		7.3
active	9623655	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
active	9623656	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	199.53	CHEMBL5903	Homo sapiens	pKi		6.7
active	9623657	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	125.89	CHEMBL5903	Homo sapiens	pKi		6.9
inactive	9623658	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623659	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	501.19	CHEMBL5903	Homo sapiens	pKi		6.3
active	9623660	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
active	9623661	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	100.0	CHEMBL5903	Homo sapiens	pKi		7.0
active	9623662	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1n[nH]c2c(-c3ccccc3)cccc12		CHEMBL1991008	=	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
inactive	9623663	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623664	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623665	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623666	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
active	9623667	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
active	9623668	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	1000.0	CHEMBL5903	Homo sapiens	pKi		6.0
active	9623669	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	63095.73	CHEMBL5903	Homo sapiens	pKi		4.2
active	9623670	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623671	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	39.81	CHEMBL5903	Homo sapiens	pKi		7.4
active	9623672	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	=	Ki	nM	199.53	CHEMBL5903	Homo sapiens	pKi		6.7
active	9623673	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	125.89	CHEMBL5903	Homo sapiens	pKi		6.9
inactive	9623674	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623675	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623676	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623677	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	199.53	CHEMBL5903	Homo sapiens	pKi		6.7
active	9623678	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	=	Ki	nM	10000.0	CHEMBL5903	Homo sapiens	pKi		5.0
inactive	9623679	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623680	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623681	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623682	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
inactive	9623683	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623684	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623685	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	15848.93	CHEMBL5903	Homo sapiens	pKi		4.8
inactive	9623686	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623687	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623688	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623689	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCO)c2)n1		CHEMBL2007073	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623690	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623691	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623692	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623693	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	1.585	CHEMBL5903	Homo sapiens	pKi		8.8
active	9623694	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1nn(C)c(=O)c(N)c1-c1ccccc1		CHEMBL1987240	=	Ki	nM	50118.72	CHEMBL5903	Homo sapiens	pKi		4.3
active	9623695	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	398.11	CHEMBL5903	Homo sapiens	pKi		6.4
inactive	9623696	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623697	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623698	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623699	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	=	Ki	nM	100000.0	CHEMBL5903	Homo sapiens	pKi		4.0
inactive	9623700	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623701	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623702	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1000.0	CHEMBL5903	Homo sapiens	pKi		6.0
active	9623703	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
active	9623704	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
active	9623705	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	7943.28	CHEMBL5903	Homo sapiens	pKi		5.1
inactive	9623706	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623707	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	31.62	CHEMBL5903	Homo sapiens	pKi		7.5
inactive	9623708	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623709	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623710	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623711	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623712	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	=	Ki	nM	1584.89	CHEMBL5903	Homo sapiens	pKi		5.8
active	9623713	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
active	9623714	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	630.96	CHEMBL5903	Homo sapiens	pKi		6.2
active	9623715	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
inactive	9623716	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623717	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(=O)[nH]c2[nH]n(-c3ccccc3)c(=O)c12		CHEMBL1985042	=	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
active	9623718	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9623719	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623720	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623721	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623722	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623723	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623724	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623725	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	2511.89	CHEMBL5903	Homo sapiens	pKi		5.6
active	9623726	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	1584.89	CHEMBL5903	Homo sapiens	pKi		5.8
inactive	9623727	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623728	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
active	9623729	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	79432.82	CHEMBL5903	Homo sapiens	pKi		4.1
inactive	9623730	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623731	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
active	9623732	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	2511.89	CHEMBL5903	Homo sapiens	pKi		5.6
active	9623733	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623734	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623735	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	50118.72	CHEMBL5903	Homo sapiens	pKi		4.3
active	9623736	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623737	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623738	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	1995.26	CHEMBL5903	Homo sapiens	pKi		5.7
inactive	9623739	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623740	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623741	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623742	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623743	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623744	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	199.53	CHEMBL5903	Homo sapiens	pKi		6.7
active	9623745	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)ccc12		CHEMBL1985232	=	Ki	nM	1258.93	CHEMBL5903	Homo sapiens	pKi		5.9
inactive	9623746	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623747	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623748	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOCC(C)Oc1cccc2[nH]nc(N)c12		CHEMBL2002736	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623749	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623750	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623751	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	=	Ki	nM	316.23	CHEMBL5903	Homo sapiens	pKi		6.5
inactive	9623752	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623753	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623754	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623755	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623756	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623757	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623758	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623759	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623760	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623761	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	63.1	CHEMBL5903	Homo sapiens	pKi		7.2
active	9623762	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	=	Ki	nM	1584.89	CHEMBL5903	Homo sapiens	pKi		5.8
active	9623763	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
active	9623764	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	398.11	CHEMBL5903	Homo sapiens	pKi		6.4
active	9623765	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	19952.62	CHEMBL5903	Homo sapiens	pKi		4.7
active	9623766	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	39.81	CHEMBL5903	Homo sapiens	pKi		7.4
active	9623767	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	3162.28	CHEMBL5903	Homo sapiens	pKi		5.5
inactive	9623768	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623769	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623770	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	=	Ki	nM	25118.86	CHEMBL5903	Homo sapiens	pKi		4.6
inactive	9623771	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623772	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	=	Ki	nM	39810.72	CHEMBL5903	Homo sapiens	pKi		4.4
active	9623773	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	158.49	CHEMBL5903	Homo sapiens	pKi		6.8
active	9623774	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623775	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
inactive	9623776	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
active	9623777	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	251.19	CHEMBL5903	Homo sapiens	pKi		6.6
active	9623778	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	Cc1cc(C(N)=O)n2nc(C(C)(C)C)cc2n1		CHEMBL1986684	=	Ki	nM	15848.93	CHEMBL5903	Homo sapiens	pKi		4.8
inactive	9623779	CHEMBL1963721	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ACVR1	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	3981.07	CHEMBL5903	Homo sapiens	pKi		5.4
	12173750	CHEMBL2212088	Inhibition of ACVR1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	12185166	CHEMBL2216364	Inhibition of ACVR1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	pIC50		5.0
	13321791	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	CN1CCN(c2ccc(-c3cnc4c(-c5ccnc6ccccc56)cnn4c3)cc2)CC1		CHEMBL2385596	<	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	13321792	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCOCC6)cc5)cnc34)ccnc2c1		CHEMBL2385582	<	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	13321852	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)cc1		CHEMBL2385600	=	IC50	nM	110.0	CHEMBL5903	Homo sapiens	IC50	nM	110.0
	13321853	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL2385597	=	IC50	nM	107.9	CHEMBL5903	Homo sapiens	IC50	nM	107.9
	13322756	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	67.5	CHEMBL5903	Homo sapiens	IC50	nM	67.5
	13322763	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385579	=	IC50	nM	53.4	CHEMBL5903	Homo sapiens	IC50	nM	53.4
	13322768	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	c1cc(N2CCNCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385586	=	IC50	nM	43.0	CHEMBL5903	Homo sapiens	IC50	nM	43.0
	13322771	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	40.7	CHEMBL5903	Homo sapiens	IC50	nM	40.7
	13322774	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL511563	=	IC50	nM	33.3	CHEMBL5903	Homo sapiens	IC50	nM	33.3
	13322775	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1		CHEMBL502351	=	IC50	nM	32.0	CHEMBL5903	Homo sapiens	IC50	nM	32.0
	13322778	CHEMBL2390524	Inhibition of ALK2 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)c2cccnc2c1		CHEMBL2385591	=	IC50	nM	26.2	CHEMBL5903	Homo sapiens	IC50	nM	26.2
	13375954	CHEMBL2406116	Inhibition of ACVR1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	7.0	CHEMBL5903	Homo sapiens	INH	%	7.0
	13439908	CHEMBL2428337	Competitive binding affinity to ACVR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	13445414	CHEMBL2428337	Competitive binding affinity to ACVR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	13448473	CHEMBL2428337	Competitive binding affinity to ACVR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	13451728	CHEMBL2428337	Competitive binding affinity to ACVR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	13973393	CHEMBL3134651	Inhibition of ALK2 (unknown origin) using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	220.0	CHEMBL5903	Homo sapiens	IC50	nM	220.0
	14659681	CHEMBL3269161	Inhibition of ALK2 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	14659682	CHEMBL3269161	Inhibition of ALK2 (unknown origin) by radioisotopic assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	10005.0	CHEMBL5903	Homo sapiens	IC50	uM	10.005
	15055359	CHEMBL3380491	Inhibition of ACVR1 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	13.0	CHEMBL5903	Homo sapiens	Activity	%	13.0
	15060701	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC		CHEMBL1230714	=	Delta Tm	degrees C	13.2	CHEMBL5903	Homo sapiens	deltaTm	degrees C	13.2
	15060702	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(O)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341941	=	Delta Tm	degrees C	13.5	CHEMBL5903	Homo sapiens	deltaTm	degrees C	13.5
	15060703	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cnc(N)c(-c3cc(OC)c(OC)c(OC)c3)c2)ccc1O		CHEMBL3341942	=	Delta Tm	degrees C	13.9	CHEMBL5903	Homo sapiens	deltaTm	degrees C	13.9
	15060704	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3cccc(NS(C)(=O)=O)c3)cnc2N)cc(OC)c1OC		CHEMBL3341943	=	Delta Tm	degrees C	14.4	CHEMBL5903	Homo sapiens	deltaTm	degrees C	14.4
	15060705	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3cccc(N4CCNCC4)c3)cnc2N)cc(OC)c1OC		CHEMBL3341944	=	Delta Tm	degrees C	14.5	CHEMBL5903	Homo sapiens	deltaTm	degrees C	14.5
	15060706	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341945	=	Delta Tm	degrees C	15.1	CHEMBL5903	Homo sapiens	deltaTm	degrees C	15.1
	15060707	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1OC		CHEMBL3341946	=	Delta Tm	degrees C	11.5	CHEMBL5903	Homo sapiens	deltaTm	degrees C	11.5
	15060708	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341947	=	Delta Tm	degrees C	13.9	CHEMBL5903	Homo sapiens	deltaTm	degrees C	13.9
	15060709	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341948	=	Delta Tm	degrees C	12.1	CHEMBL5903	Homo sapiens	deltaTm	degrees C	12.1
	15060710	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccc2c(c1)OCCO2		CHEMBL3341949	=	Delta Tm	degrees C	9.5	CHEMBL5903	Homo sapiens	deltaTm	degrees C	9.5
	15060711	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1		CHEMBL3341950	=	Delta Tm	degrees C	8.6	CHEMBL5903	Homo sapiens	deltaTm	degrees C	8.6
	15060712	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	CC(C)Oc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341951	=	Delta Tm	degrees C	8.5	CHEMBL5903	Homo sapiens	deltaTm	degrees C	8.5
	15060713	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1Cl		CHEMBL3341952	=	Delta Tm	degrees C	11.9	CHEMBL5903	Homo sapiens	deltaTm	degrees C	11.9
	15060714	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1C		CHEMBL3341953	=	Delta Tm	degrees C	11.2	CHEMBL5903	Homo sapiens	deltaTm	degrees C	11.2
	15060715	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	CNc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL3341954	=	Delta Tm	degrees C	0.3	CHEMBL5903	Homo sapiens	deltaTm	degrees C	0.3
	15060716	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N(C)C)cc(OC)c1OC		CHEMBL3341955	=	Delta Tm	degrees C	0.6	CHEMBL5903	Homo sapiens	deltaTm	degrees C	0.6
	15060717	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	Delta Tm	degrees C	14.1	CHEMBL5903	Homo sapiens	deltaTm	degrees C	14.1
	15060718	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2Cl)cc(OC)c1OC		CHEMBL3341788	=	Delta Tm	degrees C	12.8	CHEMBL5903	Homo sapiens	deltaTm	degrees C	12.8
	15060719	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	Delta Tm	degrees C	13.7	CHEMBL5903	Homo sapiens	deltaTm	degrees C	13.7
	15060720	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2OC)cc(OC)c1OC		CHEMBL3341790	=	Delta Tm	degrees C	1.1	CHEMBL5903	Homo sapiens	deltaTm	degrees C	1.1
	15060721	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccnc2ccccc12		CHEMBL3341791	=	Delta Tm	degrees C	10.4	CHEMBL5903	Homo sapiens	deltaTm	degrees C	10.4
	15060722	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	Nc1ncc(-c2cccc(N3CCNCC3)c2)cc1-c1ccnc2ccccc12		CHEMBL3341792	=	Delta Tm	degrees C	9.9	CHEMBL5903	Homo sapiens	deltaTm	degrees C	9.9
	15060723	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cccc2ncccc12		CHEMBL3341793	=	Delta Tm	degrees C	9.4	CHEMBL5903	Homo sapiens	deltaTm	degrees C	9.4
	15060724	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)cc(OC)c1OC		CHEMBL3341794	=	Delta Tm	degrees C	14.2	CHEMBL5903	Homo sapiens	deltaTm	degrees C	14.2
	15060725	CHEMBL3365185	Inhibition of purified human ALK2 kinase Q207D mutant (201-499 residues) by RT-PCR analysis	B	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)c1		CHEMBL3341795	=	Delta Tm	degrees C	12.8	CHEMBL5903	Homo sapiens	deltaTm	degrees C	12.8
	15060751	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC		CHEMBL1230714	=	IC50	nM	35.0	CHEMBL5903	Homo sapiens	IC50	nM	35.0
Not Determined	15060752	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(O)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341941		IC50			CHEMBL5903	Homo sapiens	IC50		
Not Determined	15060753	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cnc(N)c(-c3cc(OC)c(OC)c(OC)c3)c2)ccc1O		CHEMBL3341942		IC50			CHEMBL5903	Homo sapiens	IC50		
	15060754	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3cccc(NS(C)(=O)=O)c3)cnc2N)cc(OC)c1OC		CHEMBL3341943	=	IC50	nM	6.0	CHEMBL5903	Homo sapiens	IC50	nM	6.0
	15060755	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3cccc(N4CCNCC4)c3)cnc2N)cc(OC)c1OC		CHEMBL3341944	=	IC50	nM	17.0	CHEMBL5903	Homo sapiens	IC50	nM	17.0
	15060756	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341945	=	IC50	nM	10.0	CHEMBL5903	Homo sapiens	IC50	nM	10.0
	15060757	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1OC		CHEMBL3341946	=	IC50	nM	23.0	CHEMBL5903	Homo sapiens	IC50	nM	23.0
	15060758	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341947	=	IC50	nM	14.0	CHEMBL5903	Homo sapiens	IC50	nM	14.0
	15060759	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341948	=	IC50	nM	86.0	CHEMBL5903	Homo sapiens	IC50	nM	86.0
	15060760	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccc2c(c1)OCCO2		CHEMBL3341949	=	IC50	nM	1870.0	CHEMBL5903	Homo sapiens	IC50	nM	1870.0
Not Determined	15060761	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1		CHEMBL3341950		IC50			CHEMBL5903	Homo sapiens	IC50		
	15060762	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	CC(C)Oc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341951	=	IC50	nM	790.0	CHEMBL5903	Homo sapiens	IC50	nM	790.0
	15060763	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1Cl		CHEMBL3341952	=	IC50	nM	63.0	CHEMBL5903	Homo sapiens	IC50	nM	63.0
	15060764	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1C		CHEMBL3341953	=	IC50	nM	110.0	CHEMBL5903	Homo sapiens	IC50	nM	110.0
Not Determined	15060765	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	CNc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL3341954		IC50			CHEMBL5903	Homo sapiens	IC50		
Not Determined	15060766	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N(C)C)cc(OC)c1OC		CHEMBL3341955		IC50			CHEMBL5903	Homo sapiens	IC50		
	15060767	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	15.0	CHEMBL5903	Homo sapiens	IC50	nM	15.0
Not Determined	15060768	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2Cl)cc(OC)c1OC		CHEMBL3341788		IC50			CHEMBL5903	Homo sapiens	IC50		
	15060769	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	24.0	CHEMBL5903	Homo sapiens	IC50	nM	24.0
Not Determined	15060770	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2OC)cc(OC)c1OC		CHEMBL3341790		IC50			CHEMBL5903	Homo sapiens	IC50		
	15060771	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccnc2ccccc12		CHEMBL3341791	=	IC50	nM	120.0	CHEMBL5903	Homo sapiens	IC50	nM	120.0
	15060772	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2cccc(N3CCNCC3)c2)cc1-c1ccnc2ccccc12		CHEMBL3341792	=	IC50	nM	110.0	CHEMBL5903	Homo sapiens	IC50	nM	110.0
	15060773	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cccc2ncccc12		CHEMBL3341793	=	IC50	nM	270.0	CHEMBL5903	Homo sapiens	IC50	nM	270.0
	15060774	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)cc(OC)c1OC		CHEMBL3341794	=	IC50	nM	10.0	CHEMBL5903	Homo sapiens	IC50	nM	10.0
Not Determined	15060775	CHEMBL3365510	Inhibition of human recombinant human ALK2 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)c1		CHEMBL3341795		IC50			CHEMBL5903	Homo sapiens	IC50		
	15060877	CHEMBL3365515	Inhibition of ALK2 (unknown origin) expressed in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	27.0	CHEMBL5903	Homo sapiens	IC50	nM	27.0
	15149190	CHEMBL3395786	Inhibition of ACVR1 (ALK2) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	15149191	CHEMBL3395786	Inhibition of ACVR1 (ALK2) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	15149192	CHEMBL3395786	Inhibition of ACVR1 (ALK2) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	15149193	CHEMBL3395786	Inhibition of ACVR1 (ALK2) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	15149194	CHEMBL3395786	Inhibition of ACVR1 (ALK2) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	15149901	CHEMBL3395783	Inhibition of ALK2 (unknown origin) assessed as phosphorylation of ATF-2 at 5.5 uM by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	=	Inhibition	%	60.6	CHEMBL5903	Homo sapiens	INH	%	60.6
	15622520	CHEMBL3588248	Inhibition of human recombinant ALK2 by LanthaScreen Binding assay	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	7.0	CHEMBL5903	Homo sapiens	IC50	nM	7.0
	15756114	CHEMBL3631720	Inhibition of ALK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	85.25	CHEMBL5903	Homo sapiens	INH	%	85.25
	15757709	CHEMBL3631720	Inhibition of ALK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-3.19	CHEMBL5903	Homo sapiens	INH	%	-3.19
	15757985	CHEMBL3631720	Inhibition of ALK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	10.4	CHEMBL5903	Homo sapiens	INH	%	10.4
303512	16273405	CHEMBL3706170	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 M. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 M ATP and test compounds.	B	CN(C)CCCOc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL3668019	=	IC50	nM	26.68	CHEMBL5903	Homo sapiens	IC50	nM	26.68
303513	16298498	CHEMBL3706170	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 M. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 M ATP and test compounds.	B	c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1		CHEMBL331465	=	IC50	nM	2570.0	CHEMBL5903	Homo sapiens	IC50	nM	2570.0
303515	16299839	CHEMBL3706170	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 M. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 M ATP and test compounds.	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	148.1	CHEMBL5903	Homo sapiens	IC50	nM	148.1
303510	16301146	CHEMBL3706170	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 M. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 M ATP and test compounds.	B	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL2385597	=	IC50	nM	107.9	CHEMBL5903	Homo sapiens	IC50	nM	107.9
303511	16322901	CHEMBL3706170	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 M. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 M ATP and test compounds.	B	c1ccc2c(-c3cnn4cc(-c5ccc(OCCN6CCOCC6)cc5)cnc34)ccnc2c1		CHEMBL3668018	=	IC50	nM	42.77	CHEMBL5903	Homo sapiens	IC50	nM	42.77
303514	16331813	CHEMBL3706170	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 M. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 M ATP and test compounds.	B	c1ccc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)cc1		CHEMBL2385590	=	IC50	nM	40.72	CHEMBL5903	Homo sapiens	IC50	nM	40.72
	16419340	CHEMBL3748102	Inhibition of human ALK2 in presence of (33P)gamma ATP	B	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL2385597	=	IC50	nM	100.0	CHEMBL5903	Homo sapiens	IC50	uM	0.1
	16425261	CHEMBL3751123	Inhibition of ALK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-2.1	CHEMBL5903	Homo sapiens	INH	%	-2.1
	16450759	CHEMBL3762145	Inhibition of ALK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	30.3	CHEMBL5903	Homo sapiens	INH	%	30.3
	16472949	CHEMBL3768600	Inhibition of human ACVR1	B	COCCOc1cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2cc1OC		CHEMBL3763358	>	Inhibition	%	95.0	CHEMBL5903	Homo sapiens	INH	%	95.0
	16506511	CHEMBL3776507	Inhibition of recombinant human GST-tagged ACVR1 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	37.0	CHEMBL5903	Homo sapiens	INH	%	37.0
	16540734	CHEMBL3789973	Inhibition of ACVR1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	2900.0	CHEMBL5903	Homo sapiens	IC50	uM	2.9
	16540735	CHEMBL3789973	Inhibition of ACVR1 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	16613766	CHEMBL3816559	Inhibition of human ALK2 at 1 uM using casein as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	7.0	CHEMBL5903	Homo sapiens	INH	%	7.0
	16628461	CHEMBL3820164	Inhibition of human recombinant GST-tagged ALK2 (amino acid 147 end) by FRET assay	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	=	IC50	nM	1.2	CHEMBL5903	Homo sapiens	IC50	nM	1.2
	16633213	CHEMBL3826649	Inhibition of ACVR1 (unknown origin)	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C		CHEMBL3823478	=	IC50	nM	5130.0	CHEMBL5903	Homo sapiens	IC50	nM	5130.0
	16633214	CHEMBL3826649	Inhibition of ACVR1 (unknown origin)	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		CHEMBL3823101	=	IC50	nM	5090.0	CHEMBL5903	Homo sapiens	IC50	nM	5090.0
	16633276	CHEMBL3826499	Inhibition of ACVR1 (unknown origin) assessed as remaining activity at 10 uM	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		CHEMBL3823101	=	Activity	%	76.0	CHEMBL5903	Homo sapiens	Activity	%	76.0
436742	17796703	CHEMBL3889143	Biochemical Binding Assay: Biochemical binding assays (DiscoveRx) and in vitro enzyme inhibition assays (LanthaScreen, Life Technologies) were conducted to determine the binding affinity and inhibition activities of CYT-0387 to Type-I BMPR-kinases (ALK2, ALK3, and ALK6) were conducted. Transforming growth factor beta receptor 1 (TGFBR1, ALK5) was used as a control to determine the selectivity to Type-I BMPR-kinases.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	IC50	nM	8.0	CHEMBL5903	Homo sapiens	IC50	nM	8.0
436742	17796704	CHEMBL3889143	Biochemical Binding Assay: Biochemical binding assays (DiscoveRx) and in vitro enzyme inhibition assays (LanthaScreen, Life Technologies) were conducted to determine the binding affinity and inhibition activities of CYT-0387 to Type-I BMPR-kinases (ALK2, ALK3, and ALK6) were conducted. Transforming growth factor beta receptor 1 (TGFBR1, ALK5) was used as a control to determine the selectivity to Type-I BMPR-kinases.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	25.0	CHEMBL5903	Homo sapiens	Kd	nM	25.0
Inactive	17880624	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880625	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880626	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880627	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	40.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	40.0
Inactive	17880628	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880629	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880630	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880631	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880632	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880633	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880634	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880635	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880636	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880637	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880638	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880639	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880640	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880641	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880642	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880643	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880644	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880645	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880646	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880647	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880648	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880649	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880650	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880651	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880652	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880653	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880654	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	22.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	22.0
Inactive	17880655	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880656	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880657	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880658	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880659	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880660	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1415.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	1415.0
Inactive	17880661	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880662	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880663	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880664	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880665	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880666	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880667	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880668	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	249.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	249.0
Inactive	17880669	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880670	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880671	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880672	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880673	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	396.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	396.0
Inactive	17880674	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880675	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880676	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880677	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	1202.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	1202.0
Inactive	17880678	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880679	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880680	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880681	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880682	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880683	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	222.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	222.0
Inactive	17880684	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880685	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	527.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	527.0
Inactive	17880686	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880687	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880688	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880689	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880690	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880691	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880692	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880693	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	121.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	121.0
Inactive	17880694	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880695	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880696	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880697	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	4.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	4.0
Inactive	17880698	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880699	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880700	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880701	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880702	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880703	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880704	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880705	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880706	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880707	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880708	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1949.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	1949.0
Inactive	17880709	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880710	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880711	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	78.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	78.0
Inactive	17880712	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880713	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880714	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880715	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880716	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880717	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880718	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880719	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880720	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880721	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880722	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	458.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	458.0
Inactive	17880723	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880724	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	39.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	39.0
Inactive	17880725	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880726	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880727	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880728	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880729	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880730	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880731	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880732	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880733	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880734	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880735	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880736	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880737	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880738	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880739	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880740	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880741	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880742	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880743	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880744	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880745	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880746	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880747	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880748	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880749	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880750	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880751	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880752	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880753	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880754	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880755	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880756	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880757	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880758	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880759	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880760	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880761	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880762	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880763	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880764	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880765	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880766	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880767	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880768	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880769	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880770	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880771	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880772	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880773	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880774	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880775	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1310.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	1310.0
Active	17880776	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	477.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	477.0
Inactive	17880777	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880778	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880779	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880780	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880781	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880782	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880783	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880784	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880785	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880786	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880787	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880788	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	5859.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	5859.0
Inactive	17880789	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880790	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880791	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880792	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	5.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	5.0
Inactive	17880793	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880794	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880795	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880796	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880797	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880798	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880799	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880800	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880801	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880802	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880803	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880804	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880805	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880806	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880807	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880808	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880809	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880810	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880811	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880812	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880813	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880814	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880815	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880816	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880817	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880818	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880819	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880820	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880821	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880822	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880823	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880824	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880825	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880826	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880827	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	=	Kd	nM	1264.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	1264.0
Inactive	17880828	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880829	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880830	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880831	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880832	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880833	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880834	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880835	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880836	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880837	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880838	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880839	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880840	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880841	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880842	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880843	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880844	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880845	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880846	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880847	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880848	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880849	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880850	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880851	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880852	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880853	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880854	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880855	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880856	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880857	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880858	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880859	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880860	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880861	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880862	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880863	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880864	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	30000.0
Active	17880865	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	16121.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	16121.0
Active	17880866	CHEMBL3991613	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	3726.0	CHEMBL5903	Homo sapiens	Kd apparent	nM	3726.0
	17982207	CHEMBL3998847	Inhibition of human ALK2 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	=	IC50	nM	217.0	CHEMBL5903	Homo sapiens	IC50	nM	217.0
	17982208	CHEMBL3998847	Inhibition of human ALK2 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	3.26	CHEMBL5903	Homo sapiens	IC50	nM	3.26
	17982218	CHEMBL3998852	Inhibition of human ALK2 using casein as substrate in presence of 200 uM ATP by radiometric kinase assay	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	=	IC50	nM	3353.0	CHEMBL5903	Homo sapiens	IC50	nM	3353.0
	18031594	CHEMBL4007681	Inhibition of ACVR1 (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	18031595	CHEMBL4007681	Inhibition of ACVR1 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	18031596	CHEMBL4007681	Inhibition of ACVR1 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	18031597	CHEMBL4007681	Inhibition of ACVR1 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	18031598	CHEMBL4007681	Inhibition of ACVR1 (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	18114495	CHEMBL4024999	Inhibition of wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	97.0	CHEMBL5903	Homo sapiens	Activity	%	97.0
	18203389	CHEMBL4043810	Inhibition of wild-type human ACVR1 (C188 to C509 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	18253731	CHEMBL4055150	Inhibition of wild-type human ALK2 (C188 to C509 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	18253732	CHEMBL4055150	Inhibition of wild-type human ALK2 (C188 to C509 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL5903	Homo sapiens	Activity	%	96.0
	18275381	CHEMBL4118515	Inhibition of human ACVR1 (188 to 509 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	21.0	CHEMBL5903	Homo sapiens	Activity	%	21.0
	18276153	CHEMBL4119083	Inhibition of human ACVR1 (188 to 509 residues) expressed in bacterial expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	1.9	CHEMBL5903	Homo sapiens	Activity	%	1.9
	18282051	CHEMBL4120006	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (147 to end residues) at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	10.9	CHEMBL5903	Homo sapiens	INH	%	10.9
	18282370	CHEMBL4120006	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (147 to end residues) at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	25.8	CHEMBL5903	Homo sapiens	INH	%	25.8
	18440065	CHEMBL4156889	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	98.0	CHEMBL5903	Homo sapiens	Activity	%	98.0
	18484505	CHEMBL4185668	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	80.0	CHEMBL5903	Homo sapiens	Activity	%	80.0
	18485116	CHEMBL4185668	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	93.0	CHEMBL5903	Homo sapiens	Activity	%	93.0
	18507905	CHEMBL4190857	Inhibition of recombinant human ALK2 (147 to end residues) at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	0.0	CHEMBL5903	Homo sapiens	INH	%	0.0
	18655652	CHEMBL4230568	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	99.0	CHEMBL5903	Homo sapiens	Activity	%	99.0
Dose-dependent effect	18674975	CHEMBL4235486	Inhibition of ALK2 R206H mutant in HSJD-DIPG-007 cells expressing H3F3A K27M mutant derived from human patient assessed as decrease in ID1 phosphorylation incubated for 18 hrs by Western blot analysis	B	Cc1cc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4241942		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Dose-dependent effect	18674976	CHEMBL4235485	Inhibition of ALK2 R206H mutant in HSJD-DIPG-007 cells expressing H3F3A K27M mutant derived from human patient assessed as decrease in SMAD1/5/8 phosphorylation incubated for 18 hrs by Western blot analysis	B	Cc1cc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4241942		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	18674992	CHEMBL4235473	Binding affinity to human ALK2 by KdELECT assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751	=	Kd	nM	640.0	CHEMBL5903	Homo sapiens	Kd	nM	640.0
	18674993	CHEMBL4235473	Binding affinity to human ALK2 by KdELECT assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382	=	Kd	nM	330.0	CHEMBL5903	Homo sapiens	Kd	nM	330.0
	18675006	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1cc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4241942	=	IC50	nM	10.0	CHEMBL5903	Homo sapiens	IC50	uM	0.01
	18675007	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1c(-c2ccnc3ccccc23)ccc2nc(Cc3ccccc3)[nH]c(=O)c12		CHEMBL4251441	=	IC50	nM	439.0	CHEMBL5903	Homo sapiens	IC50	uM	0.439
	18675008	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	CCc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4238262	=	IC50	nM	91.0	CHEMBL5903	Homo sapiens	IC50	uM	0.091
	18675009	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751	=	IC50	nM	42.0	CHEMBL5903	Homo sapiens	IC50	uM	0.042
	18675010	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	CN(C)c1ccc(-n2cnc3ccc(-c4ccnc5ccccc45)cc3c2=O)cc1		CHEMBL4237728	=	IC50	nM	68.0	CHEMBL5903	Homo sapiens	IC50	uM	0.068
	18675011	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1CCCN1CCOCC1		CHEMBL4237276	=	IC50	nM	165.0	CHEMBL5903	Homo sapiens	IC50	uM	0.165
	18675012	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1C1CCCCC1		CHEMBL4248621	=	IC50	nM	1525.0	CHEMBL5903	Homo sapiens	IC50	uM	1.525
	18675013	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccccc1		CHEMBL4240187	=	IC50	nM	431.0	CHEMBL5903	Homo sapiens	IC50	uM	0.431
	18675014	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382	=	IC50	nM	32.0	CHEMBL5903	Homo sapiens	IC50	uM	0.032
	18675015	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1nc2ccc(-c3cccc4ncccc34)cc2c(=O)[nH]1		CHEMBL4243957	=	IC50	nM	138.0	CHEMBL5903	Homo sapiens	IC50	uM	0.138
	18675016	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)cc2c(=O)[nH]1		CHEMBL4247727	=	IC50	nM	248.0	CHEMBL5903	Homo sapiens	IC50	uM	0.248
	18675017	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cn1cnc2ccc(-c3cccc4ncccc34)cc2c1=O		CHEMBL4249920	=	IC50	nM	383.0	CHEMBL5903	Homo sapiens	IC50	uM	0.383
	18675018	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cn1cnc2ccc(-c3ccnc4ccccc34)cc2c1=O		CHEMBL4250025	=	IC50	nM	186.0	CHEMBL5903	Homo sapiens	IC50	uM	0.186
	18675019	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1c(-c2cccc3ncccc23)ccc2nc[nH]c(=O)c12		CHEMBL4250114	=	IC50	nM	194.0	CHEMBL5903	Homo sapiens	IC50	uM	0.194
	18675020	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1c(-c2ccnc3ccccc23)ccc2nc[nH]c(=O)c12		CHEMBL4243400	=	IC50	nM	220.0	CHEMBL5903	Homo sapiens	IC50	uM	0.22
	18675021	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1[nH]cnc2ccc(-c3cnn4ccccc34)cc12		CHEMBL4250951	=	IC50	nM	653.0	CHEMBL5903	Homo sapiens	IC50	uM	0.653
	18675022	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1[nH]cnc2ccc(-c3cccc4ncccc34)cc12		CHEMBL4245595	=	IC50	nM	344.0	CHEMBL5903	Homo sapiens	IC50	uM	0.344
	18675023	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1[nH]cnc2ccc(-c3ccnc4ccccc34)cc12		CHEMBL4245292	=	IC50	nM	167.0	CHEMBL5903	Homo sapiens	IC50	uM	0.167
	18675024	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1n[nH]c(C)c1-c1ccc2nc[nH]c(=O)c2c1		CHEMBL4246278	=	IC50	nM	293.0	CHEMBL5903	Homo sapiens	IC50	uM	0.293
	18675025	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1[nH]cnc2ccc(-c3c[nH]nc3C3CC3)cc12		CHEMBL4249083	=	IC50	nM	386.0	CHEMBL5903	Homo sapiens	IC50	uM	0.386
	18675026	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	CCc1n[nH]cc1-c1ccc2nc[nH]c(=O)c2c1		CHEMBL4240335	=	IC50	nM	1000.0	CHEMBL5903	Homo sapiens	IC50	uM	1.0
	18675027	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cc1n[nH]cc1-c1ccc2nc[nH]c(=O)c2c1		CHEMBL4242841	=	IC50	nM	2300.0	CHEMBL5903	Homo sapiens	IC50	uM	2.3
	18675028	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	Cn1cc(-c2ccc3nc[nH]c(=O)c3c2)cn1		CHEMBL4247078	=	IC50	nM	18200.0	CHEMBL5903	Homo sapiens	IC50	uM	18.2
	18675029	CHEMBL4235462	Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay	B	O=c1[nH]cnc2ccc(-c3cn[nH]c3)cc12		CHEMBL4248641	=	IC50	nM	8200.0	CHEMBL5903	Homo sapiens	IC50	uM	8.2
	18751075	CHEMBL4263730	Inhibition of ALK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	97.0	CHEMBL5903	Homo sapiens	INH	%	97.0
	18751268	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL4280599	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	18751269	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4ccc(S(C)(=O)=O)cc4)cnn3c2)cc1		CHEMBL4288494	=	IC50	nM	1971.0	CHEMBL5903	Homo sapiens	IC50	nM	1971.0
	18751270	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)cc4)cnn3c2)cc1		CHEMBL4277180	=	IC50	nM	526.0	CHEMBL5903	Homo sapiens	IC50	nM	526.0
	18751271	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	Cc1cc(-c2cnn3cc(-c4ccc(N5[C@@H](C)CNC[C@H]5C)cc4)cnc23)ccc1S(N)(=O)=O		CHEMBL4285138	=	IC50	nM	246.0	CHEMBL5903	Homo sapiens	IC50	nM	246.0
	18751272	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c(N)c4)cnn3c2)cc1		CHEMBL4292331	=	IC50	nM	291.0	CHEMBL5903	Homo sapiens	IC50	nM	291.0
	18751273	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4cccc(S(N)(=O)=O)c4)cnn3c2)cc1		CHEMBL4281706	=	IC50	nM	109.0	CHEMBL5903	Homo sapiens	IC50	nM	109.0
	18751274	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1		CHEMBL4288921	=	IC50	nM	19.0	CHEMBL5903	Homo sapiens	IC50	nM	19.0
	18751275	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CNS(=O)(=O)c1ccc(-c2cnn3cc(-c4ccc(N5[C@@H](C)CNC[C@H]5C)cc4)cnc23)c2ccccc12		CHEMBL4278242	=	IC50	nM	326.0	CHEMBL5903	Homo sapiens	IC50	nM	326.0
	18751276	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4ccc(S(=O)(=O)N(C)C)c5ccccc45)cnn3c2)cc1		CHEMBL4291891	=	IC50	nM	5990.0	CHEMBL5903	Homo sapiens	IC50	nM	5990.0
	18751277	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4cccc5c(S(N)(=O)=O)cccc45)cnn3c2)cc1		CHEMBL4283587	=	IC50	nM	54.0	CHEMBL5903	Homo sapiens	IC50	nM	54.0
	18751278	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	C[C@H]1CNC[C@@H](C)N1c1ccc(-c2cnc3c(-c4ccc(NS(C)(=O)=O)c5ccccc45)cnn3c2)cc1		CHEMBL4291950	=	IC50	nM	796.0	CHEMBL5903	Homo sapiens	IC50	nM	796.0
	18751279	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	NS(=O)(=O)c1ccc(-c2cnn3cc(-c4ccc(N5CCNCC5)nc4)cnc23)c2ccccc12		CHEMBL4280585	=	IC50	nM	422.0	CHEMBL5903	Homo sapiens	IC50	nM	422.0
	18751280	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CN(C)CCOc1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cn1		CHEMBL4279135	=	IC50	nM	1026.0	CHEMBL5903	Homo sapiens	IC50	nM	1026.0
	18751281	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	NS(=O)(=O)c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)nc4)cnc23)c2ccccc12		CHEMBL4290804	=	IC50	nM	738.0	CHEMBL5903	Homo sapiens	IC50	nM	738.0
	18751282	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	NS(=O)(=O)c1ccc(-c2cnn3cc(-c4ccc(C5CCNCC5)cc4)cnc23)c2ccccc12		CHEMBL4277239	=	IC50	nM	93.0	CHEMBL5903	Homo sapiens	IC50	nM	93.0
	18751283	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	NS(=O)(=O)c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)c2ccccc12		CHEMBL4285523	=	IC50	nM	63.0	CHEMBL5903	Homo sapiens	IC50	nM	63.0
	18751284	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CC(C)(CN1CCCCC1)Oc1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1		CHEMBL4278219	=	IC50	nM	47.0	CHEMBL5903	Homo sapiens	IC50	nM	47.0
	18751285	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	NS(=O)(=O)c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCCC5)cc4)cnc23)c2ccccc12		CHEMBL4288905	=	IC50	nM	48.0	CHEMBL5903	Homo sapiens	IC50	nM	48.0
	18751286	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CC(N)c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1		CHEMBL4293917	=	IC50	nM	25.0	CHEMBL5903	Homo sapiens	IC50	nM	25.0
	18751287	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CC(C)(N)c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1		CHEMBL4283315	=	IC50	nM	29.0	CHEMBL5903	Homo sapiens	IC50	nM	29.0
	18751288	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	IC50	nM	16.0	CHEMBL5903	Homo sapiens	IC50	nM	16.0
	18751289	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	NS(=O)(=O)c1ccc(-c2cnn3cc(-c4ccc(CN5CCCC5)cc4)cnc23)c2ccccc12		CHEMBL4281166	=	IC50	nM	27.0	CHEMBL5903	Homo sapiens	IC50	nM	27.0
	18751290	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CC(c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1)N1CCCC1		CHEMBL4283638	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	18751291	CHEMBL4263977	Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	17.0	CHEMBL5903	Homo sapiens	IC50	nM	17.0
	18752057	CHEMBL4264157	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	91.0	CHEMBL5903	Homo sapiens	Activity	%	91.0
	18857792	CHEMBL4307674	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	18892555	CHEMBL4314716	Inhibition of recombinant human ALK2 (142 to end residues) assessed as residual activity at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL5903	Homo sapiens	Activity	%	105.5
	18937701	CHEMBL4327580	Inhibition of human ALK2 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	94.72	CHEMBL5903	Homo sapiens	Activity	%	94.72
	18937702	CHEMBL4327580	Inhibition of human ALK2 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.58	CHEMBL5903	Homo sapiens	Activity	%	96.58
	18938421	CHEMBL4327941	Inhibition of human ALK2 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	<	Activity	%	65.0	CHEMBL5903	Homo sapiens	Activity	%	65.0
Not Determined	18938787	CHEMBL4328305	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL5903	Homo sapiens	IC50		
	18938788	CHEMBL4328305	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	43.3	CHEMBL5903	Homo sapiens	IC50	10'-8M	4.33
	18958695	CHEMBL4333268	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	47.0	CHEMBL5903	Homo sapiens	Activity	%	47.0
	18964056	CHEMBL4334962	Inhibition of human ALK2 (147 to end residues) assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	101.0	CHEMBL5903	Homo sapiens	Activity	%	101.0
	18964057	CHEMBL4334962	Inhibition of human ALK2 (147 to end residues) assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	105.0	CHEMBL5903	Homo sapiens	Activity	%	105.0
	18971779	CHEMBL4336789	Inhibition of human ALK2 (147 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	88.0	CHEMBL5903	Homo sapiens	Activity	%	88.0
	19032174	CHEMBL4349767	Inhibition of recombinant human N-terminal GST/His6-tagged ACVR1 C-terminal (A145 to C509) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-2.0	CHEMBL5903	Homo sapiens	INH	%	-2.0
Not Active	19039903	CHEMBL4351739	Inhibition of recombinant human ALK2 (142 to end residues) at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Active	19041006	CHEMBL4352267	Inhibition of human ALK2 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	19059445	CHEMBL4357746	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	19090018	CHEMBL4365592	Inhibition of wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	99.0	CHEMBL5903	Homo sapiens	Activity	%	99.0
	19091809	CHEMBL4366283	Inhibition of human ALK2 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	12.72	CHEMBL5903	Homo sapiens	INH	%	12.72
	19114510	CHEMBL4371410	Binding affinity to ACVR1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	52.0	CHEMBL5903	Homo sapiens	Kd(free)	uM	0.052
	19114682	CHEMBL4371410	Binding affinity to ACVR1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	>	Kd	nM	70.0	CHEMBL5903	Homo sapiens	Kd(free)	uM	0.07
	19144610	CHEMBL4377626	Inhibition of recombinant human ALK2 (147 to end residues) at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	11.0	CHEMBL5903	Homo sapiens	INH	%	11.0
	19147740	CHEMBL4379136	Inhibition of human recombinant ALK2 (147 to end residues) using casein as substrate incubated for 40 mins in presence of [gamma-33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	uM	10.0
	19159273	CHEMBL4382377	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	9.0	CHEMBL5903	Homo sapiens	Activity	%	9.0
	19180958	CHEMBL4387168	Inhibition of tracer 236 binding to recombinant human GST-tagged ALK2 catalytic domain (145 to 509 residues) expressed in baculovirus at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	30.5	CHEMBL5903	Homo sapiens	INH	%	30.5
	19181184	CHEMBL4387168	Inhibition of tracer 236 binding to recombinant human GST-tagged ALK2 catalytic domain (145 to 509 residues) expressed in baculovirus at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	28.0	CHEMBL5903	Homo sapiens	INH	%	28.0
	19191252	CHEMBL4389573	Inhibition of wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5903	Homo sapiens	INH	%	100.0
	19191734	CHEMBL4389096	Inhibition of wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5903	Homo sapiens	INH	%	100.0
	19200023	CHEMBL4391199	Binding affinity to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	49.0	CHEMBL5903	Homo sapiens	Activity	%	49.0
	19266306	CHEMBL4405256	Inhibition of human ACVR1 (C188 to C509 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	19271606	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	18.0	CHEMBL5903	Homo sapiens	IC50	nM	18.0
	19271607	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4434717	=	IC50	nM	10.0	CHEMBL5903	Homo sapiens	IC50	nM	10.0
	19271608	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	19271609	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655	=	IC50	nM	3.0	CHEMBL5903	Homo sapiens	IC50	nM	3.0
	19271610	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4565968	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	19271611	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(Cl)c1C(N)=O		CHEMBL4434694	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	19271612	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4440168	=	IC50	nM	24.0	CHEMBL5903	Homo sapiens	IC50	nM	24.0
	19271613	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc(C(N)=O)c(F)c1		CHEMBL4571351	=	IC50	nM	263.0	CHEMBL5903	Homo sapiens	IC50	nM	263.0
	19271614	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COCc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4440071	=	IC50	nM	687.0	CHEMBL5903	Homo sapiens	IC50	nM	687.0
	19271615	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	Cc1c(-c2ccc(C(N)=O)cc2)cncc1-c1ccc(N2CCNCC2)cc1		CHEMBL4572458	=	IC50	nM	477.0	CHEMBL5903	Homo sapiens	IC50	nM	477.0
	19271616	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O		CHEMBL4575999	=	IC50	nM	652.0	CHEMBL5903	Homo sapiens	IC50	nM	652.0
	19271617	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(=O)N(C)C		CHEMBL4460268	>	IC50	nM	1000.0	CHEMBL5903	Homo sapiens	IC50	nM	1000.0
	19271618	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	CNC(=O)c1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1OC		CHEMBL4437768	>	IC50	nM	1000.0	CHEMBL5903	Homo sapiens	IC50	nM	1000.0
	19271619	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1c(C(N)=O)csc1-c1cncc(-c2ccc(N3CCNCC3)cc2)c1C		CHEMBL4538285	>	IC50	nM	1000.0	CHEMBL5903	Homo sapiens	IC50	nM	1000.0
	19271620	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1c(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)csc1C(N)=O		CHEMBL4456061	=	IC50	nM	712.0	CHEMBL5903	Homo sapiens	IC50	nM	712.0
	19271621	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)sc1C(N)=O		CHEMBL4552750	=	IC50	nM	751.0	CHEMBL5903	Homo sapiens	IC50	nM	751.0
	19271622	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(C(N)=O)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4457642	=	IC50	nM	102.0	CHEMBL5903	Homo sapiens	IC50	nM	102.0
	19271623	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1C(N)=O		CHEMBL4535685	>	IC50	nM	1000.0	CHEMBL5903	Homo sapiens	IC50	nM	1000.0
	19271624	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4553210	=	IC50	nM	17.0	CHEMBL5903	Homo sapiens	IC50	nM	17.0
	19271626	CHEMBL4406749	Inhibition of human ALK2 using dephosphorylated casein as substrate measured after 45 mins in presence of [gamma33P]ATP by scintillation counting method	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	17.0	CHEMBL5903	Homo sapiens	IC50	nM	17.0
	19271635	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	13.0	CHEMBL5903	Homo sapiens	IC50	nM	13.0
	19271636	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4468389	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	19271637	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4526828	=	IC50	nM	3.0	CHEMBL5903	Homo sapiens	IC50	nM	3.0
	19271638	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	17.0	CHEMBL5903	Homo sapiens	IC50	nM	17.0
	19271644	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	115.0	CHEMBL5903	Homo sapiens	IC50	nM	115.0
	19271645	CHEMBL4406751	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4435320	<	IC50	nM	3.0	CHEMBL5903	Homo sapiens	IC50	nM	3.0
	19271670	CHEMBL4406755	Inhibition of human N-terminal His-tagged TEV protease site linked ALK2 Q207D mutant (201 to 499 residues) expressed in baculovirus infected Sf9 insect cells	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	15.0	CHEMBL5903	Homo sapiens	IC50	nM	15.0
	19271671	CHEMBL4406755	Inhibition of human N-terminal His-tagged TEV protease site linked ALK2 Q207D mutant (201 to 499 residues) expressed in baculovirus infected Sf9 insect cells	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	24.0	CHEMBL5903	Homo sapiens	IC50	nM	24.0
	19271676	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4553210	=	IC50	nM	55.0	CHEMBL5903	Homo sapiens	IC50	nM	55.0
	19271677	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1C(N)=O		CHEMBL4535685	=	IC50	nM	694.0	CHEMBL5903	Homo sapiens	IC50	nM	694.0
	19271678	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(C(N)=O)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4457642	=	IC50	nM	588.0	CHEMBL5903	Homo sapiens	IC50	nM	588.0
	19271679	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)sc1C(N)=O		CHEMBL4552750	=	IC50	nM	3371.0	CHEMBL5903	Homo sapiens	IC50	nM	3371.0
	19271680	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1c(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)csc1C(N)=O		CHEMBL4456061	=	IC50	nM	2811.0	CHEMBL5903	Homo sapiens	IC50	nM	2811.0
	19271681	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1c(C(N)=O)csc1-c1cncc(-c2ccc(N3CCNCC3)cc2)c1C		CHEMBL4538285	>	IC50	nM	5000.0	CHEMBL5903	Homo sapiens	IC50	nM	5000.0
	19271682	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	CNC(=O)c1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1OC		CHEMBL4437768	>	IC50	nM	5000.0	CHEMBL5903	Homo sapiens	IC50	nM	5000.0
	19271683	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(=O)N(C)C		CHEMBL4460268	>	IC50	nM	5000.0	CHEMBL5903	Homo sapiens	IC50	nM	5000.0
	19271684	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O		CHEMBL4575999	=	IC50	nM	2336.0	CHEMBL5903	Homo sapiens	IC50	nM	2336.0
	19271685	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Cc1c(-c2ccc(C(N)=O)cc2)cncc1-c1ccc(N2CCNCC2)cc1		CHEMBL4572458	=	IC50	nM	2771.0	CHEMBL5903	Homo sapiens	IC50	nM	2771.0
	19271686	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COCc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4440071	=	IC50	nM	3845.0	CHEMBL5903	Homo sapiens	IC50	nM	3845.0
	19271687	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc(C(N)=O)c(F)c1		CHEMBL4571351	=	IC50	nM	1013.0	CHEMBL5903	Homo sapiens	IC50	nM	1013.0
	19271688	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4440168	=	IC50	nM	81.0	CHEMBL5903	Homo sapiens	IC50	nM	81.0
	19271689	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(Cl)c1C(N)=O		CHEMBL4434694	=	IC50	nM	93.0	CHEMBL5903	Homo sapiens	IC50	nM	93.0
	19271690	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4565968	=	IC50	nM	178.0	CHEMBL5903	Homo sapiens	IC50	nM	178.0
	19271691	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655	=	IC50	nM	93.0	CHEMBL5903	Homo sapiens	IC50	nM	93.0
	19271692	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795	=	IC50	nM	52.0	CHEMBL5903	Homo sapiens	IC50	nM	52.0
	19271693	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4434717	=	IC50	nM	100.0	CHEMBL5903	Homo sapiens	IC50	nM	100.0
	19271694	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4435320	=	IC50	nM	19.0	CHEMBL5903	Homo sapiens	IC50	nM	19.0
	19271695	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4468389	=	IC50	nM	18.0	CHEMBL5903	Homo sapiens	IC50	nM	18.0
	19271696	CHEMBL4406758	Inhibition of C-terminal nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4526828	=	IC50	nM	52.0	CHEMBL5903	Homo sapiens	IC50	nM	52.0
Active	19271767	CHEMBL4406771	Inhibition of ALK2 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Active	19271768	CHEMBL4406771	Inhibition of ALK2 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Active	19271769	CHEMBL4406771	Inhibition of ALK2 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4434717		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	19271809	CHEMBL4406785	Inhibition of ALK2 G328V mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4553210	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	19271810	CHEMBL4406785	Inhibition of ALK2 G328V mutant (unknown origin)	B	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O		CHEMBL4575999	=	IC50	nM	171.0	CHEMBL5903	Homo sapiens	IC50	nM	171.0
	19271811	CHEMBL4406785	Inhibition of ALK2 G328V mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4440168	=	IC50	nM	4.0	CHEMBL5903	Homo sapiens	IC50	nM	4.0
	19271812	CHEMBL4406785	Inhibition of ALK2 G328V mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(Cl)c1C(N)=O		CHEMBL4434694	<	IC50	nM	2.0	CHEMBL5903	Homo sapiens	IC50	nM	2.0
	19271813	CHEMBL4406785	Inhibition of ALK2 G328V mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655	=	IC50	nM	16.0	CHEMBL5903	Homo sapiens	IC50	nM	16.0
	19271814	CHEMBL4406785	Inhibition of ALK2 G328V mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795	=	IC50	nM	3.0	CHEMBL5903	Homo sapiens	IC50	nM	3.0
	19271815	CHEMBL4406785	Inhibition of ALK2 G328V mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4435320	<	IC50	nM	2.0	CHEMBL5903	Homo sapiens	IC50	nM	2.0
	19271816	CHEMBL4406786	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4553210	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	19271817	CHEMBL4406786	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O		CHEMBL4575999	=	IC50	nM	226.0	CHEMBL5903	Homo sapiens	IC50	nM	226.0
	19271818	CHEMBL4406786	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4440168	=	IC50	nM	8.0	CHEMBL5903	Homo sapiens	IC50	nM	8.0
	19271819	CHEMBL4406786	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(Cl)c1C(N)=O		CHEMBL4434694	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	19271820	CHEMBL4406786	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655	=	IC50	nM	19.0	CHEMBL5903	Homo sapiens	IC50	nM	19.0
	19271821	CHEMBL4406786	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795	=	IC50	nM	6.0	CHEMBL5903	Homo sapiens	IC50	nM	6.0
	19271822	CHEMBL4406786	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4435320	=	IC50	nM	4.0	CHEMBL5903	Homo sapiens	IC50	nM	4.0
	19271823	CHEMBL4406787	Inhibition of ALK2 R258G mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4553210	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	19271824	CHEMBL4406787	Inhibition of ALK2 R258G mutant (unknown origin)	B	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O		CHEMBL4575999	=	IC50	nM	363.0	CHEMBL5903	Homo sapiens	IC50	nM	363.0
	19271825	CHEMBL4406787	Inhibition of ALK2 R258G mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4440168	=	IC50	nM	7.0	CHEMBL5903	Homo sapiens	IC50	nM	7.0
	19271826	CHEMBL4406787	Inhibition of ALK2 R258G mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(Cl)c1C(N)=O		CHEMBL4434694	=	IC50	nM	4.0	CHEMBL5903	Homo sapiens	IC50	nM	4.0
	19271827	CHEMBL4406787	Inhibition of ALK2 R258G mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655	=	IC50	nM	17.0	CHEMBL5903	Homo sapiens	IC50	nM	17.0
	19271828	CHEMBL4406787	Inhibition of ALK2 R258G mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795	=	IC50	nM	6.0	CHEMBL5903	Homo sapiens	IC50	nM	6.0
	19271829	CHEMBL4406787	Inhibition of ALK2 R258G mutant (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4435320	<	IC50	nM	2.0	CHEMBL5903	Homo sapiens	IC50	nM	2.0
	19303744	CHEMBL4414146	Inhibition of recombinant human catalytic GST-tagged ACVR1 expressed in baculovirus expression system assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control	B	O=C(O)c1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1O		CHEMBL4520531	=	Inhibition	%	0.0	CHEMBL5903	Homo sapiens	INH	%	0.0
	19303849	CHEMBL4414282	Inhibition of ALK2 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	34.0	CHEMBL5903	Homo sapiens	Activity	%	34.0
	20669018	CHEMBL4620272	Inhibition of biotinylated ligand binding to wild-type human ACVR1 (C188 to C509 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cccc6cnccc56)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4637601	>	Inhibition	%	80.0	CHEMBL5903	Homo sapiens	INH	%	80.0
	20690528	CHEMBL4625383	Inhibition of ALK2 (unknown origin) assessed as enzyme remaining activity at 10 uM relative to control	B	NS(=O)(=O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccc1F		CHEMBL4646566	=	Activity	%	2.0	CHEMBL5903	Homo sapiens	Activity	%	2.0
	20693887	CHEMBL4626289	Inhibition of ACVR1 G328W mutant in human SU-DIPG-XXI cells assessed as decrease in ID1 expression relative to control	B	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241	>	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	20693888	CHEMBL4626290	Inhibition of ACVR1 R206H mutant in human HSJD-DIPG-007 cells assessed as decrease in ID1 expression relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	>	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	20693889	CHEMBL4626289	Inhibition of ACVR1 G328W mutant in human SU-DIPG-XXI cells assessed as decrease in ID1 expression relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	>	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	20693890	CHEMBL4626290	Inhibition of ACVR1 R206H mutant in human HSJD-DIPG-007 cells assessed as decrease in ID1 expression relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	>	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	20693891	CHEMBL4626290	Inhibition of ACVR1 R206H mutant in human HSJD-DIPG-007 cells assessed as decrease in ID1 expression relative to control	B	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241	>	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	20693892	CHEMBL4626289	Inhibition of ACVR1 G328W mutant in human SU-DIPG-XXI cells assessed as decrease in ID1 expression relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	>	Inhibition	%	50.0	CHEMBL5903	Homo sapiens	INH	%	50.0
	20693893	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	13.0	CHEMBL5903	Homo sapiens	IC50	nM	13.0
	20693894	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	CCc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL4641897	=	IC50	nM	181.0	CHEMBL5903	Homo sapiens	IC50	nM	181.0
	20693895	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C2CC2)cc(OC)c1OC		CHEMBL4646409	=	IC50	nM	42.0	CHEMBL5903	Homo sapiens	IC50	nM	42.0
	20693896	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2OC)cc(OC)c1OC		CHEMBL4633535	=	IC50	nM	103.0	CHEMBL5903	Homo sapiens	IC50	nM	103.0
	20693897	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2N)cc(OC)c1OC		CHEMBL4635667	=	IC50	nM	461.0	CHEMBL5903	Homo sapiens	IC50	nM	461.0
	20693898	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2F)cc(OC)c1OC		CHEMBL4633121	=	IC50	nM	15.0	CHEMBL5903	Homo sapiens	IC50	nM	15.0
	20693899	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2Cl)cc(OC)c1OC		CHEMBL4642165	=	IC50	nM	16.0	CHEMBL5903	Homo sapiens	IC50	nM	16.0
	20693900	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C(F)(F)F)cc(OC)c1OC		CHEMBL4635902	=	IC50	nM	67.0	CHEMBL5903	Homo sapiens	IC50	nM	67.0
	20693901	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1OC		CHEMBL4638273	=	IC50	nM	3.0	CHEMBL5903	Homo sapiens	IC50	nM	3.0
	20693902	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4637817	=	IC50	nM	39.0	CHEMBL5903	Homo sapiens	IC50	nM	39.0
	20693903	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	=	IC50	nM	19.0	CHEMBL5903	Homo sapiens	IC50	nM	19.0
	20693904	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1F		CHEMBL4646278	=	IC50	nM	11.0	CHEMBL5903	Homo sapiens	IC50	nM	11.0
	20693905	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4643265	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	20693906	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4644571	=	IC50	nM	7.0	CHEMBL5903	Homo sapiens	IC50	nM	7.0
	20693907	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2C)cc(OC)c1OC		CHEMBL4634857	=	IC50	nM	8.0	CHEMBL5903	Homo sapiens	IC50	nM	8.0
	20693908	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(CCF)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647991	=	IC50	nM	17.0	CHEMBL5903	Homo sapiens	IC50	nM	17.0
	20693909	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648707	=	IC50	nM	22.0	CHEMBL5903	Homo sapiens	IC50	nM	22.0
	20693910	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(=O)N(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641207	=	IC50	nM	4.0	CHEMBL5903	Homo sapiens	IC50	nM	4.0
	20693911	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638544	=	IC50	nM	29.0	CHEMBL5903	Homo sapiens	IC50	nM	29.0
	20693912	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCOCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4642622	=	IC50	nM	28.0	CHEMBL5903	Homo sapiens	IC50	nM	28.0
	20693913	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCS(=O)(=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648735	=	IC50	nM	16.0	CHEMBL5903	Homo sapiens	IC50	nM	16.0
	20693914	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(C4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4635321	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	20693915	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241	=	IC50	nM	7.0	CHEMBL5903	Homo sapiens	IC50	nM	7.0
	20693916	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(C4=CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641530	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	20693917	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(C4=CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4646444	=	IC50	nM	14.0	CHEMBL5903	Homo sapiens	IC50	nM	14.0
	20693918	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4639700	=	IC50	nM	13.0	CHEMBL5903	Homo sapiens	IC50	nM	13.0
	20693919	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(CN4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638893	=	IC50	nM	20.0	CHEMBL5903	Homo sapiens	IC50	nM	20.0
	20693920	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(OC4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648102	=	IC50	nM	6.0	CHEMBL5903	Homo sapiens	IC50	nM	6.0
	20693921	CHEMBL4626169	Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(OC4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647724	=	IC50	nM	6.0	CHEMBL5903	Homo sapiens	IC50	nM	6.0
	20693922	CHEMBL4626174	Inhibition of ALK2 G328V mutant (unknown origin) by radiometric assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	8.0	CHEMBL5903	Homo sapiens	IC50	nM	8.0
	20693923	CHEMBL4626173	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	20693924	CHEMBL4626179	Inhibition of ALK2 R258G mutant (unknown origin) by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	13.0	CHEMBL5903	Homo sapiens	IC50	nM	13.0
	20693982	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	45.0	CHEMBL5903	Homo sapiens	IC50	nM	45.0
	20693983	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	CCc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL4641897	=	IC50	nM	589.0	CHEMBL5903	Homo sapiens	IC50	nM	589.0
	20693984	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C2CC2)cc(OC)c1OC		CHEMBL4646409	=	IC50	nM	159.0	CHEMBL5903	Homo sapiens	IC50	nM	159.0
	20693985	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2OC)cc(OC)c1OC		CHEMBL4633535	=	IC50	nM	233.0	CHEMBL5903	Homo sapiens	IC50	nM	233.0
	20693986	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2N)cc(OC)c1OC		CHEMBL4635667	=	IC50	nM	255.0	CHEMBL5903	Homo sapiens	IC50	nM	255.0
	20693987	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2F)cc(OC)c1OC		CHEMBL4633121	=	IC50	nM	32.0	CHEMBL5903	Homo sapiens	IC50	nM	32.0
	20693988	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2Cl)cc(OC)c1OC		CHEMBL4642165	=	IC50	nM	57.0	CHEMBL5903	Homo sapiens	IC50	nM	57.0
	20693989	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C(F)(F)F)cc(OC)c1OC		CHEMBL4635902	=	IC50	nM	184.0	CHEMBL5903	Homo sapiens	IC50	nM	184.0
	20693990	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1OC		CHEMBL4638273	=	IC50	nM	15.0	CHEMBL5903	Homo sapiens	IC50	nM	15.0
	20693991	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4637817	=	IC50	nM	440.0	CHEMBL5903	Homo sapiens	IC50	nM	440.0
	20693992	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	=	IC50	nM	98.0	CHEMBL5903	Homo sapiens	IC50	nM	98.0
	20693993	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1F		CHEMBL4646278	=	IC50	nM	49.0	CHEMBL5903	Homo sapiens	IC50	nM	49.0
	20693994	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4643265	=	IC50	nM	56.0	CHEMBL5903	Homo sapiens	IC50	nM	56.0
	20693995	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4644571	=	IC50	nM	73.0	CHEMBL5903	Homo sapiens	IC50	nM	73.0
	20693996	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2C)cc(OC)c1OC		CHEMBL4634857	=	IC50	nM	40.0	CHEMBL5903	Homo sapiens	IC50	nM	40.0
	20693997	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(CCF)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647991	=	IC50	nM	178.0	CHEMBL5903	Homo sapiens	IC50	nM	178.0
	20693998	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648707	=	IC50	nM	267.0	CHEMBL5903	Homo sapiens	IC50	nM	267.0
	20693999	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(=O)N(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641207	=	IC50	nM	149.0	CHEMBL5903	Homo sapiens	IC50	nM	149.0
	20694000	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638544	=	IC50	nM	59.0	CHEMBL5903	Homo sapiens	IC50	nM	59.0
	20694001	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCOCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4642622	=	IC50	nM	334.0	CHEMBL5903	Homo sapiens	IC50	nM	334.0
	20694002	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCS(=O)(=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648735	=	IC50	nM	169.0	CHEMBL5903	Homo sapiens	IC50	nM	169.0
	20694003	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(C4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4635321	=	IC50	nM	54.0	CHEMBL5903	Homo sapiens	IC50	nM	54.0
	20694004	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241	=	IC50	nM	29.0	CHEMBL5903	Homo sapiens	IC50	nM	29.0
	20694005	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(C4=CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641530	=	IC50	nM	47.0	CHEMBL5903	Homo sapiens	IC50	nM	47.0
	20694006	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(C4=CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4646444	=	IC50	nM	102.0	CHEMBL5903	Homo sapiens	IC50	nM	102.0
	20694007	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4639700	=	IC50	nM	83.0	CHEMBL5903	Homo sapiens	IC50	nM	83.0
	20694008	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(CN4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638893	=	IC50	nM	108.0	CHEMBL5903	Homo sapiens	IC50	nM	108.0
	20694009	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(OC4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648102	=	IC50	nM	31.0	CHEMBL5903	Homo sapiens	IC50	nM	31.0
	20694010	CHEMBL4626181	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(OC4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647724	=	IC50	nM	67.0	CHEMBL5903	Homo sapiens	IC50	nM	67.0
	20694069	CHEMBL4626184	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 G328V mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	6.0	CHEMBL5903	Homo sapiens	IC50	nM	6.0
	20694070	CHEMBL4626185	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 G356D mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	16.0	CHEMBL5903	Homo sapiens	IC50	nM	16.0
	20694071	CHEMBL4626186	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 Q207D mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	7.0	CHEMBL5903	Homo sapiens	IC50	nM	7.0
	20694072	CHEMBL4626187	Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 R206H mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	12.0	CHEMBL5903	Homo sapiens	IC50	nM	12.0
	22393845	CHEMBL4667707	Binding affinity to human wild type partial length ACVR1 (C188 to C509 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Kd	nM	1000.0	CHEMBL5903	Homo sapiens	Kd	nM	1000.0
	22393846	CHEMBL4667707	Binding affinity to human wild type partial length ACVR1 (C188 to C509 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	Kd	nM	1300.0	CHEMBL5903	Homo sapiens	Kd	nM	1300.0
	22393890	CHEMBL4667725	Inhibition of human wild type partial length ALK2 (C188 to C509 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)cc(OC)c1OC		CHEMBL3925728	=	Inhibition	%	80.0	CHEMBL5903	Homo sapiens	INH	%	80.0
	22393891	CHEMBL4667725	Inhibition of human wild type partial length ALK2 (C188 to C509 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	COc1cc(Nc2ccnc3cc(C#N)ccc23)cc(OC)c1OC		CHEMBL4575895	=	Inhibition	%	80.0	CHEMBL5903	Homo sapiens	INH	%	80.0
	22393892	CHEMBL4667725	Inhibition of human wild type partial length ALK2 (C188 to C509 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	COc1cc(Nc2ccnc3cc(C(F)(F)F)ccc23)cc(OC)c1OC		CHEMBL4746133	=	Inhibition	%	80.0	CHEMBL5903	Homo sapiens	INH	%	80.0
	22393893	CHEMBL4667725	Inhibition of human wild type partial length ALK2 (C188 to C509 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	COc1cc(Nc2ccnc3cc(I)ccc23)cc(OC)c1OC		CHEMBL4740155	=	Inhibition	%	80.0	CHEMBL5903	Homo sapiens	INH	%	80.0
	22393894	CHEMBL4667725	Inhibition of human wild type partial length ALK2 (C188 to C509 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	COc1cc(Nc2ccnc3cc(Br)ccc23)cc(OC)c1OC		CHEMBL4782290	=	Inhibition	%	80.0	CHEMBL5903	Homo sapiens	INH	%	80.0
	22423839	CHEMBL4674495	Inhibition of human ALK2 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	26.92	CHEMBL5903	Homo sapiens	Activity	%	26.92
	22423840	CHEMBL4674495	Inhibition of human ALK2 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	27.46	CHEMBL5903	Homo sapiens	Activity	%	27.46
Not Active	22424844	CHEMBL4674741	Inhibition of ALK2 (unknown origin) at 30 uM	B	C=C(c1ccc2c(c1)CC(C)(C)c1c(N)ncnc1-2)[C@H]1CC[C@H](N)CC1		CHEMBL4779461		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	22813219	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1ccc(Nc2nccc(-c3c[nH]nc3-c3cccnc3)n2)cc1		CHEMBL4798765	=	IC50	nM	684.0	CHEMBL5903	Homo sapiens	IC50	uM	0.684
	22813220	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1ccc(Nc2nccc(-c3c(-c4cccnc4)nn4c3COCC4)n2)cc1		CHEMBL4747414	=	IC50	nM	167.0	CHEMBL5903	Homo sapiens	IC50	uM	0.16699999999999998
Not Determined	22813221	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cccc(Nc2nccc(-c3c(-c4cccnc4)nn4c3COCC4)n2)c1		CHEMBL4790983		IC50			CHEMBL5903	Homo sapiens	IC50		
Not Determined	22813222	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1ccccc1Nc1nccc(-c2c(-c3cccnc3)nn3c2COCC3)n1		CHEMBL4763186		IC50			CHEMBL5903	Homo sapiens	IC50		
Not Determined	22813223	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	Clc1ccc(Nc2nccc(-c3c(-c4cccnc4)nn4c3COCC4)n2)cc1		CHEMBL4793800		IC50			CHEMBL5903	Homo sapiens	IC50		
	22813224	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	c1cncc(-c2nn3c(c2-c2ccnc(Nc4ccc(N5CCOCC5)cc4)n2)COCC3)c1		CHEMBL4749510	=	IC50	nM	65.8	CHEMBL5903	Homo sapiens	IC50	uM	0.0658
	22813225	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	c1cncc(-c2nn3c(c2-c2ccnc(Nc4ccc(N5CCNCC5)cc4)n2)COCC3)c1		CHEMBL4744674	=	IC50	nM	21.7	CHEMBL5903	Homo sapiens	IC50	uM	0.0217
	22813226	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	CN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccnc5)nn5c4COCC5)n3)cc2)CC1		CHEMBL4776838	=	IC50	nM	24.7	CHEMBL5903	Homo sapiens	IC50	uM	0.0247
	22813227	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccnc5)nn5c4COCC5)n3)cc2)CC1		CHEMBL4748071	=	IC50	nM	18.2	CHEMBL5903	Homo sapiens	IC50	uM	0.0182
	22813228	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5ccccc5)nn5c4COCC5)n3)cc2)CC1		CHEMBL4760836	=	IC50	nM	276.0	CHEMBL5903	Homo sapiens	IC50	nM	276.0
	22813229	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5ccccn5)nn5c4COCC5)n3)cc2)CC1		CHEMBL4793870	=	IC50	nM	665.0	CHEMBL5903	Homo sapiens	IC50	nM	665.0
	22813230	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5ccncc5)nn5c4COCC5)n3)cc2)CC1		CHEMBL4799263	=	IC50	nM	2890.0	CHEMBL5903	Homo sapiens	IC50	nM	2890.0
	22813231	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccnc5)nn5c4CCC5)n3)cc2)CC1		CHEMBL4797111	=	IC50	nM	28.9	CHEMBL5903	Homo sapiens	IC50	nM	28.9
	22813232	CHEMBL4714250	Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccnc5)nn5c4CCCC5)n3)cc2)CC1		CHEMBL4749744	=	IC50	nM	24.9	CHEMBL5903	Homo sapiens	IC50	nM	24.9
	22813233	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	COc1ccc(Nc2nccc(-c3c[nH]nc3-c3cccnc3)n2)cc1	Non standard unit for type	CHEMBL4798765	=	INH	nM	38.8	CHEMBL5903	Homo sapiens	INH	nM	38.8
Not Determined	22813234	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	COc1ccc(Nc2nccc(-c3c(-c4cccnc4)nn4c3COCC4)n2)cc1		CHEMBL4747414		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Determined	22813235	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	COc1cccc(Nc2nccc(-c3c(-c4cccnc4)nn4c3COCC4)n2)c1		CHEMBL4790983		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	22813236	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	COc1ccccc1Nc1nccc(-c2c(-c3cccnc3)nn3c2COCC3)n1		CHEMBL4763186	=	Inhibition	%	-3.9	CHEMBL5903	Homo sapiens	INH	%	-3.9
	22813237	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	Clc1ccc(Nc2nccc(-c3c(-c4cccnc4)nn4c3COCC4)n2)cc1		CHEMBL4793800	=	Inhibition	%	73.0	CHEMBL5903	Homo sapiens	INH	%	73.0
Not Determined	22813238	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	c1cncc(-c2nn3c(c2-c2ccnc(Nc4ccc(N5CCOCC5)cc4)n2)COCC3)c1		CHEMBL4749510		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Determined	22813239	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	c1cncc(-c2nn3c(c2-c2ccnc(Nc4ccc(N5CCNCC5)cc4)n2)COCC3)c1		CHEMBL4744674		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Determined	22813240	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	CN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccnc5)nn5c4COCC5)n3)cc2)CC1		CHEMBL4776838		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Determined	22813241	CHEMBL4714251	Inhibition of human ALK2 R206H mutant at 0.3 uM using casein as substrate incubated for 2 hrs in presence of 10 uM ATP by radiometric hotspot assay relative to control	B	COCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccnc5)nn5c4COCC5)n3)cc2)CC1		CHEMBL4748071		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	22844323	CHEMBL4721186	Inhibition of human ALK2 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	101.49	CHEMBL5903	Homo sapiens	Activity	%	101.49
	22844616	CHEMBL4721291	Inhibition of human wild type partial length ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	108.16	CHEMBL5903	Homo sapiens	Activity	%	108.16
	22884159	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN1CCN(c2ccc(-c3ccn4c(-c5ccnc6ccccc56)cnc4c3)cc2)CC1		CHEMBL4783586	=	IC50	nM	24.0	CHEMBL5903	Homo sapiens	IC50	nM	24.0
	22884160	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN1CCN(c2ccc(-c3ccn4c(-c5csc6cncnc56)cnc4c3)cc2)CC1		CHEMBL4761728	=	IC50	nM	55.8	CHEMBL5903	Homo sapiens	IC50	nM	55.8
	22884161	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN1CCN(c2ccc(-c3ccn4c(-c5csc6nccnc56)cnc4c3)cc2)CC1		CHEMBL4790396	=	IC50	nM	1.0	CHEMBL5903	Homo sapiens	IC50	nM	1.0
	22884162	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN1CCN(c2ccc(-c3ccn4c(-c5cccc6ncsc56)cnc4c3)cc2)CC1		CHEMBL4788637	=	IC50	nM	10.4	CHEMBL5903	Homo sapiens	IC50	nM	10.4
	22884163	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C)CC5)cc4)ccn23)c2ncnn2c1		CHEMBL4796887	=	IC50	nM	148.0	CHEMBL5903	Homo sapiens	IC50	nM	148.0
	22884164	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN1CCN(c2ccc(-c3ccn4c(-c5ccnc6ccsc56)cnc4c3)cc2)CC1		CHEMBL4754026	=	IC50	nM	14.0	CHEMBL5903	Homo sapiens	IC50	nM	14.0
	22884165	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN1CCN(c2ccc(-c3ccn4c(-c5ccnc6ccc(F)cc56)cnc4c3)cc2)CC1		CHEMBL4795028	=	IC50	nM	15.0	CHEMBL5903	Homo sapiens	IC50	nM	15.0
	22884166	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C)CC5)cc4)ccn23)c2cc(C(F)(F)F)ccc2n1		CHEMBL4784045	=	IC50	nM	135.0	CHEMBL5903	Homo sapiens	IC50	nM	135.0
	22884167	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C)CC5)cc4)ccn23)c2ccc(F)cc2n1		CHEMBL4784557	=	IC50	nM	38.1	CHEMBL5903	Homo sapiens	IC50	nM	38.1
	22884168	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C)CC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4759531	=	IC50	nM	17.3	CHEMBL5903	Homo sapiens	IC50	nM	17.3
	22884169	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C)CC5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4792932	=	IC50	nM	17.8	CHEMBL5903	Homo sapiens	IC50	nM	17.8
	22884170	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2ccccc2n1		CHEMBL4740381	=	IC50	nM	8.0	CHEMBL5903	Homo sapiens	IC50	nM	8.0
	22884171	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4788859	=	IC50	nM	10.9	CHEMBL5903	Homo sapiens	IC50	nM	10.9
	22884172	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4786529	=	IC50	nM	32.2	CHEMBL5903	Homo sapiens	IC50	nM	32.2
	22884173	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C(C)C)CC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4778527	=	IC50	nM	216.0	CHEMBL5903	Homo sapiens	IC50	nM	216.0
	22884174	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5C[C@H](C)O[C@H](C)C5)nc4)ccn23)c2ccccc2n1		CHEMBL4798287	=	IC50	nM	46.3	CHEMBL5903	Homo sapiens	IC50	nM	46.3
	22884175	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN[C@H](C)C5)nc4)ccn23)c2cc(F)ccc2n1		CHEMBL4757577	=	IC50	nM	14.7	CHEMBL5903	Homo sapiens	IC50	nM	14.7
	22884176	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C(C)C)CC5)nc4)ccn23)c2ccccc2n1		CHEMBL4741939	=	IC50	nM	6.3	CHEMBL5903	Homo sapiens	IC50	nM	6.3
	22884177	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCN(C6CC6)CC5)nc4)ccn23)c2ccccc2n1		CHEMBL4797386	=	IC50	nM	15.6	CHEMBL5903	Homo sapiens	IC50	nM	15.6
	22884178	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CC6(C5)CC(F)(F)C6)nc4)ccn23)c2ccccc2n1		CHEMBL4781547	=	IC50	nM	148.0	CHEMBL5903	Homo sapiens	IC50	nM	148.0
	22884179	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4cnc(N5CCC6(CCCN6)C5)c(C)c4)ccn23)c2ccccc2n1		CHEMBL4757547	=	IC50	nM	37.0	CHEMBL5903	Homo sapiens	IC50	nM	37.0
	22884180	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(OC5CCN(C)CC5)nc4)ccn23)c2cc(F)ccc2n1		CHEMBL4756639	>	IC50	nM	10000.0	CHEMBL5903	Homo sapiens	IC50	nM	10000.0
	22884181	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2ccccc2n1		CHEMBL4742906	<	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	22884182	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4790557	<	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	22884183	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4778971	<	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	22884184	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5COCCN5)cc4)ccn23)c2ccccc2n1		CHEMBL4779300	<	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	22884185	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5COCCN5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4746124	<	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	22884186	CHEMBL4727748	Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5COCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4753476	=	IC50	nM	5.6	CHEMBL5903	Homo sapiens	IC50	nM	5.6
	22886511	CHEMBL4728248	Binding affinity to ACVR1 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	6.0	CHEMBL5903	Homo sapiens	deltaTm	degrees C	6.0
	22952748	CHEMBL4766685	Inhibition of human ALK2 (147 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	99.0	CHEMBL5903	Homo sapiens	Activity	%	99.0
	22972879	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	24.0	CHEMBL5903	Homo sapiens	IC50	nM	24.0
	22972880	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	COc1cc(NS(C)(=O)=O)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4779127	=	IC50	nM	31.0	CHEMBL5903	Homo sapiens	IC50	nM	31.0
	22972881	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCS(=O)(=O)Nc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4776443	=	IC50	nM	86.0	CHEMBL5903	Homo sapiens	IC50	nM	86.0
	22972882	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4782562	=	IC50	nM	108.0	CHEMBL5903	Homo sapiens	IC50	nM	108.0
	22972883	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	COc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4792227	=	IC50	nM	239.0	CHEMBL5903	Homo sapiens	IC50	nM	239.0
	22972884	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	COc1cc(NS(C)(=O)=O)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4784430	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	22972885	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4800115	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	nM	9.0
	22972886	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	COc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4781705	=	IC50	nM	11.0	CHEMBL5903	Homo sapiens	IC50	nM	11.0
	22972887	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	COc1cc(NS(=O)(=O)c2ccccc2)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4776631	=	IC50	nM	5.0	CHEMBL5903	Homo sapiens	IC50	nM	5.0
	22972888	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCOc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4795976	=	IC50	nM	299.0	CHEMBL5903	Homo sapiens	IC50	nM	299.0
	22972889	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1C		CHEMBL4781290	=	IC50	nM	355.0	CHEMBL5903	Homo sapiens	IC50	nM	355.0
	22972890	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1OC		CHEMBL4786742	=	IC50	nM	3545.0	CHEMBL5903	Homo sapiens	IC50	nM	3545.0
	22972891	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1O		CHEMBL4786295	=	IC50	nM	387.0	CHEMBL5903	Homo sapiens	IC50	nM	387.0
	22972892	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1C		CHEMBL4800562	=	IC50	nM	2120.0	CHEMBL5903	Homo sapiens	IC50	nM	2120.0
	22972893	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1OC		CHEMBL4781373	=	IC50	nM	57.0	CHEMBL5903	Homo sapiens	IC50	nM	57.0
	22972894	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(C)c1OC		CHEMBL4788375	=	IC50	nM	395.0	CHEMBL5903	Homo sapiens	IC50	nM	395.0
	22972895	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(F)c1OC		CHEMBL4789724	=	IC50	nM	348.0	CHEMBL5903	Homo sapiens	IC50	nM	348.0
	22972896	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(Cl)c1OC		CHEMBL4793153	=	IC50	nM	202.0	CHEMBL5903	Homo sapiens	IC50	nM	202.0
	22972897	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(F)c1OC		CHEMBL4781201	=	IC50	nM	29.0	CHEMBL5903	Homo sapiens	IC50	nM	29.0
	22972898	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)NCc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1OC		CHEMBL4783273	=	IC50	nM	145.0	CHEMBL5903	Homo sapiens	IC50	nM	145.0
	22972899	CHEMBL4771084	Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3cccc(N4CCNCC4)c3)cnc2N)cc(F)c1OC		CHEMBL4799077	=	IC50	nM	522.0	CHEMBL5903	Homo sapiens	IC50	nM	522.0
Not Active	22972942	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc1OC		CHEMBL4786544		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972943	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(S(C)(=O)=O)cc3)cnc2N)ccc1OC		CHEMBL4800323		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972944	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3cccc(S(C)(=O)=O)c3)cnc2N)ccc1OC		CHEMBL4780183		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972945	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccccc3S(C)(=O)=O)cnc2N)ccc1OC		CHEMBL4778280		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972946	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(F)c1OC		CHEMBL4798442		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972947	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(F)c1OC		CHEMBL4782505		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972948	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)N1CCOc2ccc(-c3cc(-c4ccc(N5CCNCC5)cc4)cnc3N)cc21		CHEMBL4797951		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972949	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)N1CCc2ccc(-c3cc(-c4ccc(N5CCNCC5)cc4)cnc3N)cc21		CHEMBL4792038		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972950	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc2c1OCCO2		CHEMBL4789064		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972951	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OCC)c1OC		CHEMBL4783654		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	22972952	CHEMBL4771097	Inhibition of human ALK2 using casein as substrate at 10 uM in presence of 10 uM [gamma33P] ATP by kinase assay	B	CC(C)Oc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4792496		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	23122225	CHEMBL4804701	Inhibition of ALK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	84000.0	CHEMBL5903	Homo sapiens	IC50	uM	84.0
	23122226	CHEMBL4804701	Inhibition of ALK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	76200.0	CHEMBL5903	Homo sapiens	IC50	uM	76.2
	23122227	CHEMBL4804701	Inhibition of ALK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	91000.0	CHEMBL5903	Homo sapiens	IC50	uM	91.0
	23122228	CHEMBL4804702	Inhibition of ALK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL5903	Homo sapiens	INH	%	75.0
	23122229	CHEMBL4804702	Inhibition of ALK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	75.0	CHEMBL5903	Homo sapiens	INH	%	75.0
	23122230	CHEMBL4804702	Inhibition of ALK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	>	Inhibition	%	90.0	CHEMBL5903	Homo sapiens	INH	%	90.0
	23122431	CHEMBL4804782	Inhibition of human ACVR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	92.0	CHEMBL5903	Homo sapiens	Activity	%	92.0
	23123126	CHEMBL4805370	Inhibition of human ACVR1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	23123759	CHEMBL4806003	Inhibition of DNA-tagged human ACVR1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	99.0	CHEMBL5903	Homo sapiens	Activity	%	99.0
	23124342	CHEMBL4806387	Inhibition of human ACVR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	23124343	CHEMBL4806387	Inhibition of human ACVR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5903	Homo sapiens	Activity	%	100.0
	23127489	CHEMBL4807633	Inhibition of ACVR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	12.0	CHEMBL5903	Homo sapiens	Activity	%	12.0
	23127490	CHEMBL4807633	Inhibition of ACVR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	48.0	CHEMBL5903	Homo sapiens	Activity	%	48.0
	23127491	CHEMBL4807633	Inhibition of ACVR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	22.0	CHEMBL5903	Homo sapiens	Activity	%	22.0
	23127786	CHEMBL4807737	Inhibition of ACVR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL5903	Homo sapiens	Activity	%	25.0
	23127787	CHEMBL4807737	Inhibition of ACVR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	25.0	CHEMBL5903	Homo sapiens	Activity	%	25.0
	23127788	CHEMBL4807737	Inhibition of ACVR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL5903	Homo sapiens	Activity	%	25.0
	23177335	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	IC50	nM	21.0	CHEMBL5903	Homo sapiens	IC50	uM	0.021
	23177336	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL4853179	=	IC50	nM	62.0	CHEMBL5903	Homo sapiens	IC50	uM	0.062
	23177337	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(Cl)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4852860	=	IC50	nM	2940.0	CHEMBL5903	Homo sapiens	IC50	uM	2.94
	23177338	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(O)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4870434	=	IC50	nM	59.0	CHEMBL5903	Homo sapiens	IC50	uM	0.059000000000000004
	23177339	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4)c(=O)n(C)c3n2)cc1		CHEMBL136244	=	IC50	nM	284.0	CHEMBL5903	Homo sapiens	IC50	uM	0.284
	23177340	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4)c(=O)n(CC)c3n2)cc1		CHEMBL136106	=	IC50	nM	4.0	CHEMBL5903	Homo sapiens	IC50	uM	0.004
	23177341	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4)c(=O)n(CCO)c3n2)cc1		CHEMBL4871544	=	IC50	nM	18.0	CHEMBL5903	Homo sapiens	IC50	uM	0.018000000000000002
	23177342	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(CCOC)c3n2)cc1		CHEMBL4859716	=	IC50	nM	18.0	CHEMBL5903	Homo sapiens	IC50	uM	0.018000000000000002
	23177343	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(Cc4ccccc4)c3n2)cc1		CHEMBL4858463	=	IC50	nM	8.0	CHEMBL5903	Homo sapiens	IC50	uM	0.008
	23177344	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(CC(C)C)c3n2)cc1		CHEMBL4847211	=	IC50	nM	9.0	CHEMBL5903	Homo sapiens	IC50	uM	0.009000000000000001
	23177345	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(Cc4cccc(S(C)(=O)=O)c4)c3n2)cc1		CHEMBL4864576	=	IC50	nM	92.0	CHEMBL5903	Homo sapiens	IC50	uM	0.092
Not Determined	23177346	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(Cc4ccc(S(C)(=O)=O)cc4)c3n2)cc1		CHEMBL4874031		IC50			CHEMBL5903	Homo sapiens	IC50		
	23177347	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(S(C)(=O)=O)cc3)nc21		CHEMBL4868894	=	IC50	nM	136.0	CHEMBL5903	Homo sapiens	IC50	uM	0.136
	23177348	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4864600	=	IC50	nM	972.0	CHEMBL5903	Homo sapiens	IC50	uM	0.972
	23177349	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4861488	=	IC50	nM	2516.0	CHEMBL5903	Homo sapiens	IC50	uM	2.516
	23177350	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2ccc(O)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4867467	=	IC50	nM	24800.0	CHEMBL5903	Homo sapiens	IC50	uM	24.8
Not Active	23177351	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	COc1ccc(-c2cc3cnc(Nc4cccc(S(C)(=O)=O)c4)nc3n(C)c2=O)cc1		CHEMBL4861447		IC50			CHEMBL5903	Homo sapiens	IC50		
	23177352	CHEMBL4815728	Inhibition of human ALK2 using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)ccc1F		CHEMBL574058	=	IC50	nM	1000.0	CHEMBL5903	Homo sapiens	IC50	uM	1.0
Not Active	23177424	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2ccc(Cl)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4864714		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	23177425	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CC(C)Cn1c(=O)c(-c2ccc(Cl)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4856366		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	23177426	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2ccc(Cl)cc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4859351		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	23177427	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2cccc(Cl)c2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4847571		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	23177428	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	Cn1c(=O)c(-c2ccc(F)cc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4867716		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	23177429	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(Cl)cc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL4849134		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	23177430	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(C(C)(C)C)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4854929		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
Not Active	23177431	CHEMBL4815744	Inhibition of human ALK2 at 100 uM using casein as substrate incubated for 30 mins in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(OC)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4852513		Inhibition	%		CHEMBL5903	Homo sapiens	INH		
	23248218	CHEMBL4830407	Inhibition of human ALK2 using casein as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	=	IC50	nM	186.0	CHEMBL5903	Homo sapiens	IC50	nM	186.0
Not Active	23248219	CHEMBL4830407	Inhibition of human ALK2 using casein as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		IC50			CHEMBL5903	Homo sapiens	IC50		
Not Active	23248220	CHEMBL4830407	Inhibition of human ALK2 using casein as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840		IC50			CHEMBL5903	Homo sapiens	IC50		
	23248241	CHEMBL4830418	Inhibition of human ALK2 using casein as substrate assessed as enzyme activity incubated for 2 hrs by [gamma-33P]-ATP assay relative to control	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	<	Activity	%	20.0	CHEMBL5903	Homo sapiens	Activity	%	20.0
Not Active	23317266	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	80.0	CHEMBL5903	Homo sapiens	% Control	%	80.0
Not Active	23317734	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23318408	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	78.0	CHEMBL5903	Homo sapiens	% Control	%	78.0
Not Active	23318884	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23319524	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23319996	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23320674	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23321142	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23321772	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23322240	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	95.0	CHEMBL5903	Homo sapiens	% Control	%	95.0
Not Active	23322929	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23323397	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	98.0	CHEMBL5903	Homo sapiens	% Control	%	98.0
Not Active	23324251	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23324886	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23325354	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23326001	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	84.0	CHEMBL5903	Homo sapiens	% Control	%	84.0
Not Active	23326469	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23327169	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23327637	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	97.0	CHEMBL5903	Homo sapiens	% Control	%	97.0
Not Active	23328224	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	87.0	CHEMBL5903	Homo sapiens	% Control	%	87.0
Not Active	23328692	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23329242	CHEMBL4880949	ALK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	98.0	CHEMBL5903	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23329638	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23330106	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23330862	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23331330	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23331917	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	83.3	CHEMBL5903	Homo sapiens	% Control	%	83.3
Not Active	23332385	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23333101	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	74.5	CHEMBL5903	Homo sapiens	% Control	%	74.5
Not Active	23333740	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23334208	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23335187	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	94.0	CHEMBL5903	Homo sapiens	% Control	%	94.0
Not Active	23335655	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	85.0	CHEMBL5903	Homo sapiens	% Control	%	85.0
Not Active	23336282	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23336750	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	95.0	CHEMBL5903	Homo sapiens	% Control	%	95.0
Not Active	23337506	CHEMBL4881877	ACVR1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	79.0	CHEMBL5903	Homo sapiens	% Ctrl	%	79.0
Not Active	23337831	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	84.0	CHEMBL5903	Homo sapiens	% Control	%	84.0
Not Active	23338299	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	95.0	CHEMBL5903	Homo sapiens	% Control	%	95.0
Not Active	23338911	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23339379	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23340016	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23340484	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23341141	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23341609	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23342225	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	85.0	CHEMBL5903	Homo sapiens	% Control	%	85.0
Not Active	23342693	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	94.0	CHEMBL5903	Homo sapiens	% Control	%	94.0
Not Active	23343323	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	84.0	CHEMBL5903	Homo sapiens	% Control	%	84.0
Not Active	23343791	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	99.0	CHEMBL5903	Homo sapiens	% Control	%	99.0
Not Active	23344429	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	75.0	CHEMBL5903	Homo sapiens	% Control	%	75.0
Not Active	23345002	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23345470	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23346047	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	59.3	CHEMBL5903	Homo sapiens	% Control	%	59.3
Not Active	23346516	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23347126	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	98.3	CHEMBL5903	Homo sapiens	% Control	%	98.3
Not Active	23347607	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	81.8	CHEMBL5903	Homo sapiens	% Control	%	81.8
Not Active	23348186	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23348654	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	93.0	CHEMBL5903	Homo sapiens	% Control	%	93.0
Not Active	23349241	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	92.0	CHEMBL5903	Homo sapiens	% Control	%	92.0
Not Active	23349859	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23350327	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23350932	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23351400	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL5903	Homo sapiens	% Control	%	90.0
Not Active	23351955	CHEMBL4882648	ACVR1 (ALK2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	10.72	CHEMBL5903	Homo sapiens	% Inhibition	%	10.7163
Not Active	23352424	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	90.0	CHEMBL5903	Homo sapiens	% Control	%	90.0
Not Active	23352892	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	96.0	CHEMBL5903	Homo sapiens	% Control	%	96.0
Not Active	23353774	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23354242	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23354974	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23355442	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23356078	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23356546	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23357155	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23357802	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	92.0	CHEMBL5903	Homo sapiens	% Control	%	92.0
Not Active	23358270	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	92.0	CHEMBL5903	Homo sapiens	% Control	%	92.0
Not Active	23358856	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	94.3	CHEMBL5903	Homo sapiens	% Control	%	94.3
Not Active	23359454	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	88.0	CHEMBL5903	Homo sapiens	% Control	%	88.0
Not Active	23359922	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	96.0	CHEMBL5903	Homo sapiens	% Control	%	96.0
Not Active	23360507	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	85.0	CHEMBL5903	Homo sapiens	% Control	%	85.0
Not Active	23360975	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23361548	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	80.0	CHEMBL5903	Homo sapiens	% Control	%	80.0
Not Active	23362084	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23362552	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23364194	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	84.0	CHEMBL5903	Homo sapiens	% Control	%	84.0
Not Active	23364662	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	89.0	CHEMBL5903	Homo sapiens	% Control	%	89.0
Not Active	23365401	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23365944	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	88.0	CHEMBL5903	Homo sapiens	% Control	%	88.0
Not Active	23366534	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23367002	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23367464	CHEMBL4883817	ACV-R1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	94.0	CHEMBL5903	Homo sapiens	% Residual activity with Skepinone-L	%	94.0
Not Active	23367880	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	97.0	CHEMBL5903	Homo sapiens	% Control	%	97.0
Not Active	23368348	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	96.0	CHEMBL5903	Homo sapiens	% Control	%	96.0
Not Active	23368947	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23369415	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	88.0	CHEMBL5903	Homo sapiens	% Control	%	88.0
Not Active	23369967	CHEMBL4884214	ALK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	109.0	CHEMBL5903	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23370383	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23370851	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL5903	Homo sapiens	% Control	%	99.0
Not Active	23371660	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	70.0	CHEMBL5903	Homo sapiens	% Control	%	70.0
Not Active	23372128	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	88.0	CHEMBL5903	Homo sapiens	% Control	%	88.0
	23372652	CHEMBL4884617	ALK2(ACV1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5903	Homo sapiens	pIC50		6.0
	23373061	CHEMBL4884908	ALK2(ACV1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5903	Homo sapiens	pIC50		6.0
	23373422	CHEMBL4885199	ALK2(ACV1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5903	Homo sapiens	pIC50		6.0
Not Active	23374914	CHEMBL4885908	ALK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	8.0	CHEMBL5903	Homo sapiens	% Inhibition	%	8.0
Not Active	23375555	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23376023	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	89.0	CHEMBL5903	Homo sapiens	% Control	%	89.0
Not Active	23376601	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	79.0	CHEMBL5903	Homo sapiens	% Control	%	79.0
Not Active	23377070	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	82.0	CHEMBL5903	Homo sapiens	% Control	%	82.0
Not Active	23377928	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	85.0	CHEMBL5903	Homo sapiens	% Control	%	85.0
Not Active	23378396	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	89.0	CHEMBL5903	Homo sapiens	% Control	%	89.0
Not Active	23379563	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	96.0	CHEMBL5903	Homo sapiens	% Control	%	96.0
Not Active	23380031	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	83.0	CHEMBL5903	Homo sapiens	% Control	%	83.0
Not Active	23380725	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23381373	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	97.0	CHEMBL5903	Homo sapiens	% Control	%	97.0
Not Active	23381841	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	89.0	CHEMBL5903	Homo sapiens	% Control	%	89.0
Not Active	23382465	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5903	Homo sapiens	% Control	%	100.0
Not Active	23382933	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	91.0	CHEMBL5903	Homo sapiens	% Control	%	91.0
Not Active	23383688	CHEMBL4887343	ACVR1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	79.0	CHEMBL5903	Homo sapiens	% Ctrl	%	79.0
Not Active	23384174	CHEMBL4887769	ALK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.14	CHEMBL5903	Homo sapiens	% inhibition	%	5.14
Not Active	23384848	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	94.0	CHEMBL5903	Homo sapiens	% Control	%	94.0
Not Active	23385315	CHEMBL4879572	KinomeScan assay: inhibition of ACVR1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	85.0	CHEMBL5903	Homo sapiens	% Control	%	85.0
